Next Article in Journal
Study of the Antagonism of Biocontrol Strains Against the Blue-Stain Fungus of Rubberwood
Next Article in Special Issue
Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps
Previous Article in Journal
The Effect of Temperature over the Growth and Biofilm Formation of the Thermotolerant Aspergillus flavus
Previous Article in Special Issue
Ex Situ Conservation, DNA Barcoding and Enzymatic Potential Evaluation of Macrofungi (Basidiomycota, Ascomycota) from Vietnam
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Potential Medicinal Fungi from Freshwater Environments as Resources of Bioactive Compounds

by
Ilenia Cicero
1,
Giulia Mirabile
1,* and
Giuseppe Venturella
1,2
1
Department of Agricultural, Food and Forest Sciences, University of Palermo, Viale delle Scienze, Bldg. 5, 90128 Palermo, Italy
2
National Biodiversity Future Center (NBFC), Piazza Marina 61 (c/o Palazzo Steri), 90133 Palermo, Italy
*
Author to whom correspondence should be addressed.
J. Fungi 2025, 11(1), 54; https://doi.org/10.3390/jof11010054
Submission received: 16 December 2024 / Revised: 3 January 2025 / Accepted: 8 January 2025 / Published: 10 January 2025

Abstract

:
Owing to their nutritional, culinary, and nutraceutical, mushrooms are worldwide consumed and appreciated. Moreover, many of these mushrooms are also known as medicinal mushrooms since they possess several pharmacological properties attributable to a huge number of bioactive compounds derived from their sporophores. Several studies are available in the literature about in vitro and in vivo mechanisms of actions of such bioactive compounds. Most of these surveys are focused on macrofungi belonging to the genera Pleurotus, Ganoderma, or specific taxa such as Agaricus bisporus, Agaricus blazei, Boletus eduliInonotus obliquus, Hericium erinaceus, Lentinula edodes, and Grifola frondose. On the other hand, there is a lack of information on the under investigated ecological group of freshwater fungi. These fungi play a very important role in freshwater environments and some of them, belonging to Basidiomycota, are also edible and largely consumed. In this review we collected information about the medicinal properties of freshwater macro- and micromycetes. Among them, macrofungi, such as Amanita vaginata, Armillaria mellea, Armillaria tabescens, Astraeus hygrometricus, Auricularia auricula-judae, Bjerkandera adusta, Bovista nigrescens, Calocybe gambosa, Candolleomyces candolleanus, Collybia dryophila, Coprinus comatus, Cyclocybe cylindracea, Hypsizygus ulmarius, Inonotus hispidus, Lactarius controversus, Lentinus tigrinus, and Schizophyllum commune, observed in riparian habitat, and microfungi, such as Penicillium aculeatum, P. chrysogenum, and Fusarium incarnatum, isolated from aquatic plants, have been reported to have antimicrobial, anticancer, anti-inflammatory, antioxidant, antidiabetic, immunomoludatory, hypoglycaemic, and other pharmaceutical activities. Such fungal species are noteworthy since they represent an important quote of biodiversity to preserve their fundamental ecological role and a possible solution for different health problems for humans and animal farms.

1. Introduction

Mushroom consumption has increased in recent years thanks to their health-promoting effects rather than their nutritional properties. Indeed, many edible mushrooms have gained more attention as sources of bioactive compounds, including steroids, phenols, β-glucans, flavonoids, and alkaloids, that promote many pharmaceutical effects, such as antiviral, antibacterial, antifungal, anticancer, antidiabetic, hepatoprotective, cytotoxicity, anti-inflammatory, and hypocholesterolemic activities [1,2,3]. To date, it is estimated that among the 14,000 known fungal species, approximately 650 of them have shown in vitro or in vivo medicinal potential. Significant results have been obtained from terrestrial fungal species such as Agaricus spp., Ganoderma lucidum (Curtis) P. Karst., Boletus spp., Pleurotus spp., Lentinula edodes (Berk.) Pegler, Grifola frondosa (Dicks.) Gray, and Hericium erinaceus (Bull.) Pers., all of which are well known for the presence of the above-mentioned bioactive molecules [3,4,5]. Compared with the large number (ca. 4000 taxa) of freshwater fungi [6,7], very little information about medicinal properties is available about a large percentage of these fungi and their related ecological groups. Freshwater fungi spend their entire life cycle, or part of it, in freshwater environments such as lakes, ponds, rivers, streams, wetlands, etc., or colonize submerged organs of plants in freshwater habitats. They belong to 13 fungal phyla, the most numerous of which are represented by Ascomycota, while a small number of species belong to Basidiomycota. Fungi require water for all life stages: spore germination, sporophore development, substrate degradation, nutrient uptake, reproduction, and spore dispersal. They degrade organic matter through the action of enzymes that need water to break down the substrate [6]. In aquatic environments, they act mainly as dead plants and animal biomass decomposers, but they are also involved in carbon and nitrogen cycles; they can act as plant or animal parasites or symbionts [7,8,9]. In a recent study by Mirabile et al. [9], according to the goals of the National Biodiversity of Future Center (NBFC) financed by the National Recovery and Resilience Plan (NRRP), an analysis of literature and field data reported several species of freshwater fungi isolated and observed in freshwater habitats of the Italian peninsula. This review aims to display information about the medicinal properties of freshwater fungi (both macro and micromycetes) as an important source of biodiversity useful for human and animal health.

2. Medicinal Properties of Freshwater Fungi

A list of the medicinal properties of freshwater macromycetes observed in the riparian forests along the Italian peninsula, together with some freshwater micromycetes isolated from aquatic plants in the Italian territory [9,10], are reported here. In total, 19 macromycetes, growing both in terrestrial and freshwater habitats (Amanita vaginata, Armillaria mellea, Armillaria tabescens, Astraeus hygrometricus, Auricularia auricula-judae, Bjerkandera adusta, Bovista nigrescens, Calocybe gambosa, Candolleomyces candolleanus, Collybia dryophila, Coprinus comatus, Cyclocybe cylindracea, Hypsizygus ulmarius, Inonotus hispidus, Lactarius controversus, Lentinus tigrinus, Schizophyllum commune), and 3 micromycetes (Penicillium aculeatum, P. chrysogenum, and Fusarium incarnatumi) have been stated to have pharmaceutical activities (Table 1 and Table 2). The majority of macrofungi belonging to Basidiomycota phylum were found in the mixed riparian forest of Populus alba L. and Salix alba L., growing as saprotrophs on wood. In contrast, all the microfungi, belonging to Ascomycota phylum, were found in association with Phragmites australis (Cav.) Trin. ex Steud. as endophytes (Figure 1a,b).

2.1. Amanita vaginata (Bull.) Lam.

Amanita vaginata is an edible mushroom belonging to Amanitaceae. It is an ectomycorrhizal species that grows mostly in coniferous and hardwood forests. In riparian habitat, it was found associated with Alnus cordata, Carpinus betulus, and Fraxinus ornus. In the Asian region, particularly in India, this mushroom and its extracts have been deeply studied for their medicinal properties. The antibacterial activity of A. vaginata extracts was tested by Giri et al. [11]. The authors screened the antimicrobial potential of several wild edible mushrooms of West Bengal (India), among them A. vaginata. A methanolic extract was prepared and tested against pathogenic bacteria such as Staphylococcus aureus, Proteus vulgaris, Bacillus cereus, Escherichia coli, Pseudomonas aeruginosa, and Bacillus subtilis and against the pathogenic fungus Candida albicans. The antimicrobial activity was tested by using the disk diffusion method (500 µg/disk) and the results showed that the methanolic extract of A. vaginata exhibited inhibitory activity against three of the tested bacteria (S. aureus, P. vulgaris, and E. coli) and C. albicans. A. vaginata also have antioxidant properties due to their high content of polyphenols that can be useful for reducing the risk of heart diseases, but also anti-inflammatory, antiviral, antiallergic, anticarcinogenic and, immunomodulatory properties. Paloi and Acharya [12] analyzed the polyphenolic-rich fraction of A. vaginata, and found a significant level of total phenolic compounds (5.335 ± 0.28 µg gallic acid equivalent/mg of extract). Among the analyzed compounds, they found 0.81 ± 0.06 µg quercitin equivalent/mg of flavonoids, 1.0 ± 0.06, 0.6 ± 0.03, and 0.00035 ± 0.00005 µg/mg of extract of ß-carotene, lycopene, and ascorbic acid, respectively. As a result of the presence of these metabolites, A. vaginata showed a remarkable scavenging capacity against superoxide and hydroxyl radicals, chelating ability of ferrous ions, and a significant reducing power [12,13].

2.2. Armillaria mellea (Vahl) P. Kumm.

Armillaria mellea is an edible basidiomycete belonging to Physalacriaceae that acts as a necrotroph parasite in plants, causing a typical white rot that can lead the plant to death. In riparian habitat, it was observed to be associated with stumps of Populus alba, Salix alba, Tamarix Africana, and Alnus cordata. In some Asian countries, it is widespread for the treatment of many human diseases, such as insomnia, infantile convulsion, headache, microbial diseases, and neurasthenia, thanks to several bioactive compounds that have been isolated from its basidiomes. The presence of organic compounds such as β-glucans, sterols, peptides, sphingolipids, polyphenols, and other components make this fungus an important source of natural therapeutic substances [14,15]. Among the medicinal activities of A. mellea, their antioxidant capacity is among the most important. This capacity is due to the presence of phenols, carotenoids, flavonoids, and phenolic acid in A. mellea extracts. The tests that were carried out by Lung and Chang [16] and Erbiai et al. [17] using methanolic and hot water extract of Armillaria showed significant antioxidant capacity for concentrations of the extracts ranging from 0.5 to 20 mg/mL. Moreover, the extracts showed high reducing power, a DPPH radical-scavenging effect, a chelating ability on ferrous ions, and a scavenging effect on superoxide anion in a dose-dependent manner. The high efficiency in antioxidant properties was also confirmed by the EC50 values (effective concentration in which the antioxidant activity was 50%) of the extracts that were lower than 10 mg/mL.
Because of its antioxidant and antiapoptotic properties, the effect of polysaccharides obtained from A. mellea mycelium was also tested against Alzheimer’s disease. An et al. [18] tested the protective potential of polysaccharides extracted by using hot water at 80 °C from A. mellea mycelium on the induced HT22 cell apoptosis model and on Alzheimer’s disease induced in mice. A. mellea polysaccharides showed high levels of suppression of nuclear apoptosis, inhibited the accumulation of intracellular reactive oxygen, restored the potential of the mitochondrial membrane, and improved cell viability. Regarding Alzheimer’s disease induced in mice, A. mellea polysaccharides improved both horizontal movements during an autonomic activity test and endurance times in a rotarod test while decreasing the time of escape latency in a water maze test.
Methanolic extract of A. mellea also showed antibacterial and antifungal activity [19,20]. The extract was tested against the Gram-Positive bacteria Staphylococcus aureus (ATCC 6538), Listeria monocytogenes (NCTC 7973), a clinical isolate of Bacillus cereus, and Micrococcus flavus (ATCC 10240); Gram-Negative Pseudomonas aeruginosa (ATCC 27853), Salmonella typhimurium (ATCC 13311); and against the pathogenic fungi Aspergillus niger (ATCC 6275), Aspergillus achraceus (ATCC 12066), Aspergillus versicolor (ATCC 11730), Aspergillus fumigatus, Trichoderma viride (IAM 5061), Penicillium funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC 9112), Penicillium verrucosum var. cyclopium, and four strains of Candida albicans. The extract showed antimicrobial activity, equally against pathogenic fungi and bacteria, with MIC values for inhibitory activity ranging from 3.12 to 15.00 mg/mL and bactericidal effect with MBC values ranging from 6.25 to 25.0 mg/mL.
Other compounds included in A. mellea basidiomes have been associated with anticancer effects. In particular, armillarikin and sesquiterpene aryl esters were found to be active against some cancer cells, causing leukemia and hepatoma [21,22,23].

2.3. Armillaria tabescens (Scop.) Emel.

Armillaria tabescens is a plant pathogen belonging to Physalaciaceae that can infect many woody plants such as fir, oak, eucalyptus, and almond trees [24]. In freshwater habitats, it was observed on stumps of Populus alba and Salix alba as necrotroph parasites.
Some bioactive compounds produced by A. tabescens have been investigated for their medicinal potential. Herath et al. [25] tested the antimicrobial activity of 7 A. tabescens chemical compounds obtained from its ethyl acetate extract: emestrin-G, emestrin-F, cephalosporolide-E, cephalosporolide-J, 6-O-(4-O-methyl-β-D-glucopyranosyl)-8-hydroxy-2,7-dimethyl-4H-enzopyran-one, decarestrictine-C2, brassicasterol and ergosterol. They were tested against fungal and bacterial human pathogens, including Candida albicans (ATCC 90028), C. glabrata (ATCC 90030), Aspergillus fumigatus (ATCC 204305), Cryptococcus neoformans (ATCC 90113), Staphylococcus aureus (ATCC 33591), Pseudomonas aeruginosa (ATCC 27853), Escherichia coli (ATCC 35218), and Mycobacterium intracellulare (ATCC 23068). The results showed that none of the 7 tested compounds had inhibitory effect against A fumigatus, C. glabrata, and P. aeruginosa. Only emestrin-F and emestrin-G showed antimicrobial activity. The first was active only against M. intracellulare, and the latter against E. coli, S. aureus, C. albicans, and C. neoformans.
Three extracts of A. tabescens (n-hexane, ethyl acetate, and methanol) were tested for their antioxidant activity [26]. Five methods were carried out to evaluate the antioxidant capability of the extracts: β-carotene bleaching method, DPPH radical scavenging activity, ABTS cation radical scavenging activity, metal chelating activity, and cupric reducing power. The results showed that the methanol extract exhibited a better antioxidant activity than the n-hexane and ethyl acetate extracts in the β-carotene bleaching method, DPPH radical scavenging activity, and ABTS cation radical scavenging activity. In detail, the methanol extract showed 90% inhibition of linoleic acid oxidation in the β-carotene assay at concentrations of 200 and 400 µg/mL, and 34.52 ± 0.39% and 88.48 ± 1.12% at concentrations of 400 µg/mL of antioxidant activity in the DPPH and ABTS assay, respectively. Regarding cupric reducing antioxidant capacity and metal chelating activity, the n-hexane extract resulted in the most active, with an absorbance (450 nm) value of 1.07 ± 0.01 and 57.13 ± 1.87% of inhibition at concentrations of 400 µg/mL, respectively.

2.4. Astraeus hygrometricus (Pers.) Morgan

Astraeus hygrometricus is a basidiomycete belonging to Diplocystaceae. It is commonly known as hygroscopic earthstar, barometer earthstar, or false earthstar for its aptitude for water-absorbing. It can open its rays, exposing its spore sac to increasing humidity, and close them in drier conditions. It is often recorded in association with Quercus spp. and Pinus spp. or growing as a symbiont with Shorea robusta G.f. [27,28]. In freshwater ecosystems, it is frequently associated with mixed riparian forests of Tamarix africana, Salix alba, and Populus alba. Many researchers have highlighted the presence of different bioactive compounds obtained from basidiomes of A. hygrometricus. This fungus is very appreciated for its medicinal properties, especially in India and China [29,30]. Among the phytochemicals with bioactive properties those produced by A. hygrometricus are known to be both high- and low-molecular-weight compounds. The first group belongs to polysaccharides and proteins, such as lectins, D-galactose, D-glucose, D-galacturonic, D-mannose, and L-fucose, while among the low-molecular-weight-compounds, we can find three triterpenes known as Astrahygol, 3-epi-Astrahygol, and Astrhygrone, steroids, and sesquiterpenoids, such as Astrakurkurol and Astrakurkurone [31,32,33,34,35].
Several authors reported a strong antioxidant activity of the extract of A. hygrometricus. In their survey, Bisaw et al. [36] recorded the positive effect of the ethanolic extract of A. hygrometricus for hydroxyl radical scavenging activity, β-carotene bleaching inhibition, superoxide, and DPPH scavenging activities, lipid peroxidation, and nitric oxide synthase activation properties, owing to the high presence of phenolic and flavonoid compounds in the extract. Also, the methanolic extract of this mushroom showed high antioxidant activities also linked to the presence of phenolic compounds such as protocatechuic acid, salicylic acid, ferulic acid, syringic acid, and anthralinic acid [30,37]. A. hygrometricus was also tested for its antimicrobial activity against several human pathogenic bacteria such as Bacillus cereus, B. subtilis, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, Staphylococcus aureus, and Proteus vulgaris [37,38]. The methanolic extract was tested against the pathogenic bacteria by the disk diffusion method, showing antimicrobial activity against P. vulgaris, E. coli, P. aeruginosa, and C. albicans at a concentration of 500 µg/disk. The ethanolic extract of A. hygrometricus was also tested for its antimicrobial effect against Leishmania donovani promastigotes, a dangerous protozoan parasite causing visceral Leishmaniasis in humans. Lai et al. [35] were the first to isolate a new triterpene, from A. hygrometricus basidiocarp, named Astrakurkurone, that exhibited high promastigocidal activity against L. donovani. Subsequently, other researchers [39,40,41] discovered the mechanism of action of Astrakurkurone causing mitochondrial dysfunction in L. donovani and the capacity of this triterpene to induce the human cells to produce protective cytokines active against the parasite in both in vitro and in vivo tests in patients with visceral leishmniasis.
The ethanolic extract of A. hygrometricus also showed anti-diabetic activity at a dose of 500 mg/kg of body weight on alloxan-induced diabetic mice; hepatoprotective activity against CCl4 induced chronic hepatotoxicity; cardioprotective effect reducing the incidence of cardiac hypertrophy, myocardial infarction, and vascular death in cardiovascular compromised patients; anticancer activity against Ehrlinch’s ascites carcinoma cells in an animal model, apoptosis in tumor cells of mouse melanoma, HT-29 colon cancer, Dalton’s lymphoma, and sarcoma-180 [42,43,44].
Moreover, polysaccharides and proteins isolated from the aqueous extract of A. hygrometricus showed immunomodulator activity, stimulating T cells, B cells, and macrophages; amplifying phagocytic potential; cytokine production from splenocytes, thymocytes, and bone marrow cells of animal models [44,45,46].

2.5. Auricularia auricula-judae (Bull.) Quél.

Auricularia auricula-judae, also known as Jew’s ear, is a basidiomycete belonging to Auriculariaceae because of its ear-like shape and because it grows especially on elder wood (Sambucus nigra), the tree from which, according to the belief, Judas Iscariot hanged himself. It also grows on Acer pseudoplatanus L., Fagus sylvatica L., Fraxinus excelsior L., and Euonymus europaeus L. [47]. In freshwater ecosystems, it acts like a saprotroph on stumps and trunks of Populus alba and Salix alba.
Even if not widely consumed in East Asian countries, it has been frequently used as food and drugs for a long time thanks to the presence of several bioactive compounds with medicinal properties [48,49,50]. In their survey, Oli et al. [51] tested the antimicrobial potential of two protein extracts (tris buffer extract and warm aqueous extract) of A. auricula-judae against the pathogenic bacteria S. aureus, B. subtilis, E. coli, P. aeruginosa, K. pneumoniae, against the pathogenic yeast C. albicans and against the dermatophytes pathogens Trichophyton schoenleinii, T. mentagrophytes, Microsporum gypseum, and M. ferugineum. Results showed that both extracts exhibited antimicrobial effect against all the tested pathogens, except for T. mentagrophytes, M. ferugineum, and M. gypseum, with MIC values of 5 µg/mL for S. aureus, B. subtilis, P. aeruginosa, K. pneumoniae, and C. albicans, and of 2.5 µg/mL for E. coli.
Thanks to the production of polysaccharides, polyphenols, flavonoids, and melanin, A. auricula-judae shows a fundamental role in antioxidation processes against free radicals, preventing chronic diseases [52,53]. The antioxidant and anti-inflammatory activities of 30 varieties of A. auricula-judae were tested by Islam et al. [53]. Ferric reducing antioxidant power (FRAP, expressed as mmol of Fe2+ equivalents per 100 g of the sample), DPPH free radical scavenging (expressed as TE, Trolox equivalents, per g of sample), ABTS radical scavenging (expressed as TE, Trolox equivalents, per g of sample) and metal chelating ability (MCA, expressed as EDTA-2Na equivalents per g of sample) were carried out to test the antioxidant effect, and the anti-inflammatory activity was tested by the colorimetric protease inhibitory method. Results showed that FRAP values ranged from 0.53 mmol/100 g to 1.15 mmol/100 g; DPPH free radical scavenging activity values ranged from 1.50 µmol TE/g to 4.08 µmol TE/g; ABTS radical scavenging ability values ranged from 3.85 µmol TE/g to 10.04 µmol TE/g; and MCA ability values ranged from 1.59 µmol/g t3.50 µmol/g. These results indicate that the important antioxidant capability of A. auricula-judae strains can reduce Fe3+ to Fe2+ and inhibit the formation of ferrous and ferrozine complexes. Moreover, a test carried out to evaluate the anti-inflammatory activity by using the colorimetric protease inhibitory method revealed a high anti-inflammatory potential with IC50 values (anti-inflammatory activity of 50%, inhibiting concentration) ranging from 0.36 mg/mL to 0.50 mg/mL. In addition to possessing antimicrobial and antioxidant activities, A. auricula-judae seems to promote the skin wound-healing process thanks to the presence of bioactive polysaccharides. Mapoung et al. [54] tested this capability by in vitro and in vivo tests using a methanolic extract of A. auricula-judae. The in vivo tests were carried out on the HaCat cell line (human katinocystes) and primary human skin fibroblast isolated from an abdominal scar after a Cesarean practice. First of all, the effect of the A. auricula-judae extract was tested on cell proliferation, treating them with different concentrations of the fungal extract. Subsequently, the wound-healing activity was tested by horizontally scraping the monolayer confluent cells using a pipette tip and then washing them with PBS. Different concentrations of fungal extract ranging from 0.25 µg/mL were used. The effect of A. auricula-judae extract was also tested for cell migration and invasion and collage synthesis using the same extract concentrations. The results showed that both human fibroblast and keratinocyte increased proliferation, migration, and invasion process in a dose-dependent manner when treated with A. auricula-judae extract, reaching statistical significance at 20 and 25 µg/mL for both cells. Also, collagen synthesis was promoted by the treatment with fungal extract, demonstrating the high potential of in vitro, for A. auricula-judae to be used as a wounding-healing or a wound-dressing agents. With regard to in vivo tests, they were carried out on BALB/c male mice, six to eight weeks old, which were subjected to full skin excision by practicing circular wounds (5 mm in diameter). The mice were divided into three groups: one treated with 0.9% saline solution, and the others treated with 1% w/v or 2.5% w/v of fungal extract for 12 days. The results showed that the mice treated with the fungal extract showed a reduction in granulation tissue (for both of the used concentrations) and a thickening of the epidermis (for the group treated with 2.5% of fungal extract). Moreover, they showed an accumulation of fibroblast cells, a denser collagen network, and a more rapid wound closure rate if compared with the control group.

2.6. Bjerkandera adusta (Willd.) P. Karst.

Bjerkandera adusta is a basidiomycete belonging to Meruliaceae. It grows on dead wood, broad-leaved as a necrotroph. It can also act as a plant pathogen, causing white roots in living trees. Furthermore, it is widespread in America, Europe, and Asia. Thanks to the production of several enzymes that are able to degrade aromatic hydrocarbons, it is widely studied for its possible use in bioremediation and cosmetic applications (melanin decolorization) [55,56]. In freshwater environments, stumps and trunks of Populus alba and Salix alba were reported to be acting like a necrotroph parasite.
B. adusta basidiomes are rich in phenols, ergosterol, esters, squalene, and other bioactive compounds, suggesting that its cultivation could be useful for the production of secondary metabolites of medicinal interest [57]. In this regard, Soliman and El-Sayed [58] studied the potential of B. adusta as an antimicrobial agent. The ethanol extract of the fungus was tested against six pathogenic bacteria such as E. coli ATCC 25922, P. aeruginosa ATCC 7853, S. aureus ATCC 25923, Proteus mirabilis, Micrococcus luteus, and S. pneumoniae, and against the pathogenic yeast C. albicans ATCC 1031. The extract had an antimicrobial effect on all the pathogens except for P. mirabilis, with the diameter of the inhibition zone ranging from 10.0 ± 0.52 mm (P. aeruginosa ATCC 7853) to 22.0 ± 0.10 mm (M. luteus). De Oliveira et al. [59] evaluated the nutritional composition of B. adusta and its antioxidant activity. Four different extracts of B. adusta were prepared: hexane extract (EH), chloroform extract (EC), ethyl acetate extract (EAE), and methanolic extract (EMEOH). Their antioxidant potential was tested by measuring the DPPH radical scavenging activity, using the posphomolybdenum method, measuring the reducing power, and the thiobarbituric acid reactive substances (TBARS) analysis. The results showed that among the four tested extracts, only EAE (229.05 ± 1.3 µg·mL−1) and EMEOH (340.46 ± 2.0 µg·mL−1) presented DPPH radical scavenging activity; EAE (55.64 ± 2.92%) showed a better antioxidant activity than the control (ascorbic acid) in the phosphomolybdenum method; no statistically significant differences were found among the extracts in the reducing power analysis; and that EC and EH showed higher results than the control (BHT standard) in the TBARS analysis with lipid peroxidation values of 133.03% and 75.56%, respectively.

2.7. Bovista nigrescens Pers.

Bovista nigrescens is an edible basidiomycete belonging to Lycoperdaceae. It can be found in pasture land and grass in North and West Europe. In a riparian forest of Salix alba, Populus alba, and Eucalyptus camaldulensis, it grows as a saprotroph on litter.
The ethanolic extract of B. nigrescens was tested via disk diffusion assay for its antimicrobial properties against a wide group of pathogenic microorganisms: Bacillus subtilis ATCC 6633, Enterococcus durans, E. faecalis ATCC 29212, E. faecium, L. monocytogenes ATCC 7644, S. aureus ATCC 25923, S. carnosus MC1.B, S. epidermidis DSMZ 20044, S. agalactiae DSMZ 6784, Enterobacter aerogenes ATCC 13048, E. coli ATCC 25922, E. coli CFAI, Klebsiella pneumoniae, Salmonella enteritidis ATCC 13075, S. infantis, S. kentucky, S. typhimurium SL 1344, and C. albicans ATCC 10231. The extract was tested at three different concentrations: 400 µg/µL, 600 µg/µL, and 1000 µg/µL. Among the three tested concentrations, the extract at 400 µg/µL and 600 µg/µL had antimicrobial effects on B. subtilis ATCC 6633, E. aerogenes ATCC 13048, E. coli CFAI, K. pneumoniae, and S. carnosus MC1.B, while only the extract at 1000 µg/µL antimicrobial activity was also registered against S. typhimurium [60]. Bal et al. [61] tested both the antimicrobial and the antioxidant properties of B. nigrescens ethanolic and methanolic extract. To test the antimicrobial activity, an agar dilution test was carried out against S. aureus ATCC 29213, S. aureus MRSA ATCC 43300, E. faecalis ATCC 29212, E. coli ATCC 25922, P. aeruginosa ATCC 27853, Acinetobacter baumannii ATCC 19606, C. albicans ATCC 10231, C. krusei ATCC 34135, and C. glabrata ATCC 90030. Both extracts were tested at four concentrations (50, 100, 200, and 400 µg/mL). Ethanolic extract was active at 50 µg/mL against S. aureus ATCC 29213 and S. aureus MRSA ATCC 43300; at 100 µg/mL, it was active against E. faecalis ATCC 29212, E. coli ATCC 25922, Acinetobacter baumannii, ATCC 19606, C. albicans ATCC 10231, C. krusei ATCC 34135, and C. glabrata ATCC 90030; and against P. aeruginosa ATCC 27853, it was active at 200 µg/mL. Regarding methanolic extract, it showed antimicrobial activity against S. aureus ATCC 29213, S. aureus MRSA ATCC 43300, A. baumannii ATCC 19606, and C. glabrata ATCC 90030 at a 100 µg/mL concentration; against E. faecalis ATCC 29212, E. coli ATCC 25922, C. albicans ATCC 10231, and C. krusei ATCC 34135 at a 200 µg/mL concentration; and against P. aeruginosa ATCC 27853 at a 400 µg/mL concentration. The same extracts were also tested for their antioxidant activity by using the Rel Assay Diagnostic evaluating Total Antioxidant Status (TAS), Total Oxidant Status (TOS), and Oxidative Stress Index (OSI). The results showed that ethanolic extract showed the highest TAS value (4.140 ± 0.172 mmol/L), while methanolic extract showed the highest TOS (9.655 ± 0.160 µmol/L) and OSI values (0.261 ± 0.011 TOS/(TAS × 10)), demonstrating that B. nigrescens possess not only antimicrobial potential but also antioxidants properties.

2.8. Calocybe gambosa (Fr.) Donk

Calocybe gambosa is an edible basidiomycete, known as the St. George mushroom, belonging to Lyophyllaceae, and commonly growing in European grasslands. In freshwater ecosystems it was observed as a terricolous saprotroph in the riparian forests of S. alba and P. alba. Research carried out on C. gambosa basidiomes revealed a high content of flavonoids, phenolic compounds, ascorbic acid, tocopherols, β-carotene, lycopene, and the presence of other bioactive compounds that can be connected to some pharmaceutical effects [62]. In a recent study, the methanolic and aqueous extracts of C. gambosa were tested for their DPPH radical scavenging activity. The same extracts and a crude peptide extract were also tested for their cytotoxicity against human epithelial cervix adenocarcinoma (HeLa), epithelial lung carcinoma (A549), colon adenocarcinoma (LS174) cells, and human normal lung fibroblasts (MRC-5) [63]. Both extracts showed antiradical activity at the DPPH test, with IC50 1145.91 ± 88.60 µg mL−1 for aqueous extract and IC50 626.10 ± 25.20 µg mL−1 for methanolic extract. Regarding cytotoxicity, both methanolic and aqueous extracts did not show any activity against cancer and healthy cells (IC50 >200 mg mL−1). A cytotoxic effect was exhibited by the peptide extract in colon cancer cell line LS174 with an IC50 168.87 ± 9.72 µg mL−1. Other studies on the antioxidant activity of C. gambosa were carried out by other authors [64]. The methanolic extracts of the fungus was analyzed with several assays such as DPPH radical scavenging activity, ferricyanide/Prussian blue assay, TBARS assay and β–carotene/linoleate assay. Results showed that the antioxidant activity varied on the basis of the methodology. In particular, the best activity was showed with the ferricyanide/Prussian blue assay with an IC50 of 0.89 ± 0.02 mg/mL. The same extract was also tested for its antimicrobial activity against 8 pathogenic bacteria (S. aureus, B. cereus, M. luteus, L. monocytogenes, P. aeruginosa, E. cloacae, S. typhimurium and E. coli) using a modified microdilution method and against 8 pathogenic fungi (Aspergillus ochraceus, A. fumigatus, A. niger, A. versicolor, Penicillium funiculosum, P. ochrochloron, P. verrucosum var. cyclopium, and Trichoderma viride) by serial sub-cultivation of a 2 µL of the tested sample. The best antimicrobial effect was registered against S. aureus with MIC values of 9.30 mg/mL and MBC value of 18.60 mg/mL, among bacteria, and against T. viride and A. versicolor, among fungi, with MIC value of 10.94 mg/mL and MFC value of 43.75 mg/mL for both species.

2.9. Candolleomyces candolleanus (Fr.) D. Wächt and A. Melzer

The basidiomycete Candellomyces candolleanus belongs to Psathyrellaceae. It occurs in Europe, Asia, Africa, and North America. In the wild, it can act as facultative mycorrhizal fungus on Poa annua L. or as a saprotroph on cottonwood, elm, and beech trees. Its consumption is not widespread while in Iraq is traditionally used as medicinal food [65]. In freshwater habitats, it is reported as a saprotroph on dead wood stumps of P. alba, S. alba, Tamarix africana, and A. cordata. C. candolleanus sporophores produce a number of diterpenoids with significant antibacterial activity. Liu et al. [66] tested the antibacterial potential of two diterpenoids, Psathyrin A and B, extracted from C. candolleanus. The compounds were tested against S. aureus, S. enterica, and P. aeruginosa and MIC50 values were calculated. Results showed that both the compounds had antimicrobial effecst on S. aureus and S. enterica while there is no activity on P. aeruginosa.
Due to the capacity of ZnO nanoparticles to exhibit antibacterial properties against both Gram-Positive and Gram-Negative bacteria, Ali et al. [67] synthesized them from an aqueous extract of C. candolleanus for the first time. They tested the ZnO nanoparticles against B. subtilis, B. meurellus, E. coli, and Acetobacter rhizospherensis by disk diffusion assay in dark conditions and under UV-A light. The results showed that they affected all the tested bacteria in a dose-dependent manner in both conditions but the most sensitive were E. coli in dark conditions and B. subtilis under UV-A light.
Recently, Zhao et al. [68] discovered seven new guanacastane diterpenoids, produced by liquid fermentation of C. candolleanus, named psayamin (compound 1), psathins A, B, C (compounds 4, 5, 6), psathins D, E (compounds 7, 8), and psathin F (compound 9) were tested for their acetylcholinesterase inhibitory activity, cytotoxic, and apoptosis activities. Among the seven tested compounds, psayamin showed the highest anti-acetylcholinesterase activity (IC50 at 37.3 μM), significant cytotoxicity against five tumor cells including those of lung cancer A549, leukemia HL-60, liver cancer SMMC-7721, colon cancer SW480, and breast cancer MCF-7 (IC50 ranging from 10.87 ± 0.24 to 15.96 ± 0.30 μM), and remarkably induced apoptosis against HL-60 in a dose-dependent manner.

2.10. Gymnopus dryophylus (Bull.) Murril

Gymnopus dryophylus is a basidiomycete that belongs to the Tricholomataceae. It grows mainly in leaf litter of deciduous and coniferous forests (forests of P. alba, A. cordata, C. sativa, S. alba, Pinus nigra) both in terrestrial and freshwater habitats. Very little information are known about its medicinal properties. In recent decades, Pacheco-Sánchez et al. [69] studied the inhibitory effects of a polysaccharide extracted from Collybia dryophila (the previous name of G. dryophilus) against the nitric oxide (NO) production induced by lipopolysaccharide (LPS) and gamma interferon (IFNγ) or induced only by LPS in EAW 264.7 cells (a murine macrophage cell line). They found out that the fungal polysaccharide significantly inhibited the NO production in a dose-dependent manner without a cytotoxic effect on vital cells and a direct effect on nitric oxide synthase gene expression.

2.11. Coprinus comatus (O.F. Müll.) Pers.

Coprinus comatus is a basidiomycete belonging to Agaricaceae. It is also known as the shaggy ink cap because its gills are initially white, then pink, and then finally black, producing a black liquid similar to ink, which is filled with spores. It grows in grasslands and meadows in Europe and North America, and in China, it is very appreciated as food and is widely consumed [70]. In the freshwater riparian forests, it grows as a saprotroph of the litter of P. alba, S. alba, A. cordata, F. ornus, and Castanea sativa. Different studies reported several physiological and beneficial effects of C. comatus. Organic extracts of some C. comatus were screened to test their antiandrogenic activity and their capacity to interfere with the androgen receptor, which is the major drug target of prostate cancer therapy [71]. Fungal extracts were prepared from 7 strains of C. comatus by using ethyl acetate (EA), hexane (H), chloroform (C), and ethanol (E) and tested against human MDA-kb2 breast carcinoma, DU-145, and PC-3 AR-independent and LNCaP androgen-dependent prostate cancer cell lines. The authors found that all C. comatus extracts inhibit AR by more than 60%. The strains CC542-C, CC734-H, and CC263-E showed the capacity to inhibit the proliferation of LNCaP cells with IC50 values below 50 µg/mL. These strains showed that lower effects were tested against the proliferation of PC-3 and MDA-Kb2 cell lines, demonstrating high selectivity toward the LNCaP cells. Moreover, CC734-EA, CC96-EA, and CC252-H extracts showed inhibitory activity against the proliferation of both LNCaP and PC-3 cell lines but were less effective against MDA-Kb2, confirming that C. comatus could be used as a natural antiandrogenic modulator for the treatment of prostatic cancer. Other anticancer activities of C. comatus were reported by Zhang et al. [72], which showed how a glycan-binding protein (Y3) isolated from the fungus had inhibitory effects against human T-cell leukemia in a dose-dependent manner, causing 90% of the Jurkat cells’ apoptosis.
Among the medicinal properties of C. comatus, its anti-diabetic activity was deeply investigated. Liu et al. [73] studied the effects of C. comatus polysaccharide extracts CCPF (extract obtained from fungal fragments) and CCPP (extract obtained from fungal powder). Hyperglycaemia was induced in male adult ICR mice that were then treated with different concentrations of each extract. Blood samples were obtained from treated and control mice to detect the glucose levels in the blood. The results showed that the mice group treated with a daily administration of CCPF at a concentration of 1000 mg/kg presented a significant reduction in the blood glucose level compared to the control group, while no significant effects were detected for CCPP extract. The anti-diabetic properties of C. comatus polysaccharides were also confirmed by Gao et al. [74] and Ratnaningtyas et al. [75]. In the first case, the authors investigated the effects of C. comatus mycelium polysaccharide (CMP) against the diabetic nephropathic in streptozotocin-induced mice. The treatment with CMP (400 mg/kg/d) significantly improved the insulin resistance of the mice by suppressing kidney dysfunction, inflammation, and renal oxidative stress. On the other hand, Ratnaningtyas and co-workers, tested on streptozotocin induced hyperglycemic rats by using an ethanolic extract of C. comatus. They measured the efficacy of the fungal extract by evaluating their glucose in the blood, insulin, glycosylated hemoglobin (HbA1c), dipeptidyl peptidase-4 (DPP-4), glucagon-like peptide-1 (GLP-1), and glutathione (GLS) levels. Experimental mice were treated with fungal extracts for 14 days using three different concentrations: 250, 500, or 750 mg/kg. At the dose of 750 mg/kg, rats’ blood glucose levels were reduced by 26.69% and DPP-4 by 6.97%, while the dose of 500 mg/kg reduced HbA1c by 4.30%, GLP-1 by 71.09%, and GHS by 11.19%, while it increased insulin levels by 13.83%.
C. comatus was also tested for its antioxidant properties against carbon tetrachloride-induced liver injury in rats [76]. C. comatus extract was orally administered at concentrations of 0.835, 1.67, and 3.34 g/kg/d for 42 days, after which they were euthanized for blood and liver collection and histopathological examination. The results showed that the treatments with fungal extracts improved the antioxidant capabilities in a dose-dependent manner, and had positive effects on tetrachloride-induced liver damage in rats, proved by a decrease in aminotransferase level in serum and lipid peroxidation intensity. Also, histological analysis confirmed the antioxidant and hepatoprotective effects of C. comatus.

2.12. Cyclocybe cylindracea (DC.) Vizzini and Angelini

C. cylindracea is a saprotroph basidiomycete belonging to Strophariaceae, also known as poplar mushroom. It is one of the most appreciated edible fungi and its worldwide cultivated. It grows on dead wood of broad-leaved trees, especially Populus spp., Ulmus spp., Salix spp., and Sambucus spp. In freshwater ecosystems, it was found on stumps of P. alba and S. alba riparian forests. In Asia, it is consumed for its antioxidant capability. In this regard, several studies have been carried out to highlight the antioxidant potential of this mushroom. Sevindik et al. [77] investigated the total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) of C. cylindracea ethanolic extract. The TAS and TOS values reached 4.325 mmol/L and 21.109 µmol/L, showing that C. cylindracea has a rich antioxidant potential. Krüzsely et al. [78] investigated the scavenging activity of a β-carboline alkaloid isolated from the methanol extract of C. cylindracea by applying the DPPH radical scavenging assay. This compound exhibited a marked radical scavenging activity with EC50 values of 119.1 ± 1.2 µg/mL. Recently, Landingin et al. [79] tested and confirmed the scavenging activity of an ethanolic extract of C. cylindracea by DPPH radical scavenging assay.

2.13. Hypsizygus ulmarius (Bull.) Redhead

Also known as elm oyster or blue oyster mushroom, H. ulmarius is an edible mushroom belonging to Lyophyllaceae. It grows as a saprotroph or parasite, causing brown rot on elm, box elder, and beech in temperate forests of North America, Asia, and Europe. In the freshwater habitat, such species grow as a saprotroph on stumps of P. alba and S. alba. In Japan and China, it represents one of the most important consumed mushrooms thanks to its flavor, nutritional content, and medicinal properties [80,81]. Several studies reported the pharmaceutical potential of H. ulmarius. Greeshma et al. [82] evaluated the antioxidant, anti-inflammatory, and antitumor activities of the ethanolic extract of H. ulmarius sporophore and mycelium. The antioxidant activity was tested in vitro by DPPH radical-scavenging activity, hydroxyl radical-scavenging activity, inhibition of lipid peroxidation, nitric oxide (NO) scavenging activity, ABTS radical-scavenging activity, and ferric-reducing antioxidant power (FRAP). Both mycelium and sporophore extracts showed significant DPPH radical-scavenging activity at a concentration of 1000 µg/mL with a percentage of inhibition of 85% (sporophore) and 88.3% (mycelium). Similar percentages were also reached at the same concentration for the hydroxyl radical-scavenging activity, while the mycelium extract showed more potential at inhibiting lipid peroxidation in NO-scavenging activity and FRAP assay. On the contrary, the sporophore extract showed the highest percentage of inhibition at ABTS radical-scavenging activity with respect to mycelium extract. To test anti-inflammatory activity, Swiss albino mice were treated with formalin or carrageenan for the induction of chronic paw edema. Both extracts reduced the paw thickness at all the tested concentrations (1000, 500, and 250 mg/kg), with respect to the control, but mycelium extract showed higher activity than sporophore extract. The preventive and curative antitumor effect of the extracts against Dalton’s Lymphoma Ascites cell lines was also tested, and results showed that both extracts significantly reduced DLA-induced solid tumor and had a preventive antitumor effect in a dose-dependent manner, but mycelium extract showed, in general, a higher antitumor effect than sporophore extract.
Important pharmaceutical effects are attributed to H. ulmarius polysaccharides named HUP, HUP-1, and HUP-2, obtained by hot water extraction. The polysaccharides showed high antioxidant potential and high reducing power when they were tested for DPPH and ABTS radical scavenging activity [83,84,85,86]. HUP was also tested for liver protection against alcohol-induced liver damage in alcohol-intoxicated rats, showing that a pre-treatment with high or low doses of the extract significantly reduced both the levels of hepatic oxidative stress and the serum enzyme behaviors, restoring biochemical constituents levels and improving the serum lipid levels, the serum enzymatic levels, the and non-enzymatic antioxidants levels in liver [87]. The polysaccharides HUP-1 and HUP-2 were tested for in vitro anticoagulant and anticancer effects. Anticoagulant tests were carried out by measuring Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), and Thrombin Time, showing that HUP-2 had a significant effect in the extension of APTT while HUP-1 considerably prolonged the three of them. Regarding anticancer activity, HUP-1 and HUP-2 were tested against the PC3 human prostate cancer cell line (HUP-2), and the proliferation of HeLA, HT29, HepG2, and PC3 (HUP-1) cell lines showing significant inhibitory effects and cytotoxic activity against all of them [84,86].
Other tests were carried out with the methanolic extract of H. ulmarius and its petroleum ether and ethyl acetate fractions, regarding antidiabetic and anti-inflammatory potential. The antidiabetic effects were evaluated through the in vitro inhibition of salivary α-amylase, salivary sucrase, and α-glucosidase activities, alongside the anti-inflammatory activity with the inhibition of enzyme lipoxygenase (LOX), myeloperoxidase (MPO), and cyclooxygenase (COX) enzymes. The results showed that even if the three tested H. ulmarius extracts had pharmaceutical effects, the ethyl acetate fraction had both the highest antidiabetic and anti-inflammatory activity compared to methanolic extract and petroleum ether fraction [81].

2.14. Inonotus hispidus (Bull.) P. Karst.

Inonotus hispidus is a brown-rot basidiomycete belonging to Hymenochaetaceae. It acts as a parasite or a facultative saprotroph on European and Chinese broadleaf trees such as Morus alba L., Fraxinus mandschurica Rupr., Populus euphratica Olivier, Acer saccharum Marshall, Sorbus aucuparia L., and Ulmus minor Mill. In freshwater habitats, it can be observed as a saprotroph on the trunks of P. alba and S. alba. In China, it has been used as traditional medicine for treating cancer, stomach problems, diabetes, and other diseases, and for this reason, it represents one of the mushrooms with the highest economic importance [87].
The anticancer activity of I. hispidus is widely investigated. Several monomers have been discovered to have anticancer effects. The compounds MBP (3,3′-methylene-bis [6-(3,4-hydroxystyryl)-4-hydroxy-2H-pyran-2-one) and HDE ((4S,5S)-4-Hydroxy-3,5-dimethoxycyclohex-2-enone), isolated from the methanolic extract of I. hispidus basidiomes, were tested for their inhibitory effect on the proliferation of HepG2, MCF-7, Hela, A549, and H22 cancer cell lines. The results show that the compounds inhibited the proliferation of all the cancer cell lines, but the highest inhibition activity was registered against HePG2 [88,89]. Another compound named WIH3, isolated from fermented mycelium of I. hispidus, was tested against Hep-3B, melanoma cells B16, Hela, and MCF-7 cancer cell lines, showing strong inhibitory effects at IC50 values of 37.39 µg/mL, 29.32 µg/mL, 47.03 µg/mL, and 58.01 µg/mL, respectively [90].
Another important pharmaceutical property of I. hispidus is its antioxidant and antimicrobial effect. Angelini et al. [91] carried out a comparative analysis of the antimicrobial and antioxidant activities of methanolic extracts obtained from sporophores and liquid-cultured mycelia of I. hispidus. The antioxidant activity was measured by the DPPH and β-carotene/linoleic acid assay. Compared to the control (Trolox), sporophore and mycelia extracts showed an activity of 17.2 and 22.1%, respectively, in the DPPH assay, while in the β-carotene/linoleic acid assay, it showed activity values of 15.44 and 11.44%, respectively, compared to the control activity (BHT, butylated hydroxytoluene). The antimicrobial effect was tested against P. aeruginosa (ATCC 15442), E. coli (ATCC 10536), Salmonella typhi, S. aureus (ATCC 6538), B. cereus (ATCC 12826), C. albicans (YEPGA 6183), C. tropicalis (YEPGA 6184), A. tubingensis (PeruMicA 21), and A. minutus (PeruMica 22). The activity of basidiomes extract was higher than mycelia extract, with MIC values ranging from 0.17 to 1.71 μg mL−1.

2.15. Lactarius controversus Pers.

Lactarius controversus is a basidiomycete belonging to Russulaceae which is widespread in Europe and grows in symbiosis with Salix spp., and in North America; it is associated with Populus spp. and Salix spp. In riparian environments, it grows as ectomychorrhizal in the mixed forests of S. alba, P. alba, A. cordata, F. ornus, and C. sativa. In Europe, due to its acrid taste, it is not considered edible, but in Serbia and Turkey, it is widely consumed for its beneficial effects [92,93].
The ethanol and water extracts of L. controversus revealed radical scavenging effects on DPPH, OH, NO, and SOA radicals and FRAP potential. In particular, the water extract exhibited the highest DPPH radical scavenging effect (IC50 219.37 ± 5.7 µg ml–1), while the ethanol extract showed the highest FRAP capability (10.93 ± 0.9 mg ascorbic acid equivalents/g extract dry weight). The same extracts were tested for their antiproliferative activities against the human breast cell line MCF 7, showing that the ethanolic extract had better antitumor activity than the water extract [92]. The antioxidant effect of L. controversus was also registered for its methanol extract. The activity was evaluated by reducing Mo(VI) to Mo(V), linoleic acid peroxidation inhibition, power, metal chelating, superoxide anion scavenging, free radical scavenging, hydrogen peroxide scavenging, and peroxide scavenging activity, showing in all the assays their highest values at concentrations of 100 µg/mL [93]. Moreover, the hexane extract and methanolic extract of L. controversus were shown to possess antimicrobial activity. Hexane extract was tested against S. aureus ATCC 25922, B. subtilis ATCC6633, and E. coli ATCC25923 and showed inhibitory activity only against S. aureus ATCC 25922 at MIC and MBC concentrations of 3.12 mg/mL and 6.25 mg/mL, respectively. The methanolic extract was tested against S. aureus ATCC 6535, B. cereus ATCC 7064, S. epidermidis ATCC 12228, E. coli W3110, P. aeruginosa ATCC 27853, E. aerogenes ATCC 13048, and C. albicans ATCC 10231 as well as clinical isolates of E. coli, P. aeruginosa, P. vulgaris, E. aerogenes, Acinetobacter baumanii, Morganella morganii, Methicillin-resistant S. aureus-MRSA, Methicillin.resistant coagulase (-) Staphylococcus–MRKNS, showing an inhibition zone > 15 mm for E. coli W3110, P. aeruginosa ATCC 27853, B. cereus ATCC 7064, S. aureus ATCC 6535, and against the clinical isolates P. aeruginosa, P. vulgaris, and M. morganii [92,93].

2.16. Lentinus tigrinus (Bull.) Fr.

Lentinus tigrinus belonging to Polyporaceae, is a wood-rotting basidiomycete growing on fallen logs. It acts like a saprotroph on stumps of P. alba growing in riparian forests. Its strong aroma and taste make it widely used as a culinary mushroom [94]. Several surveys pointed out the pharmaceutical potential of this mushroom and its use as a functional food. The hot-water extract of L. tigrinus showed hypoglycemic activity in diabetic mice, lowering the glucose levels in their blood by 26.9% (value significantly comparable to the control) at concentrations of 100 and 250 mg/kg at the third week of treatment [95]. Hot water, ethanol, and acetonitrile extracts showed antibacterial effects against S. aureus by using a paper disk diffusion assay, with a diameter of inhibition zone of 8, 12.7, and 9.48 mm, respectively [95,96]. The antimicrobial effect of other extracts of L. tigrinus was confirmed by Sevinkid et al. [97]. In their study, they tested ethanol, methanol, and dichlorometane extracts against S. aureus ATCC 29213, S. aureus MRSA ATCC 43300, E. faecalis ATCC 29212, E. coli ATCC 25922, P. aeruginosa ATCC 27853, Acinetobacter baumannii ATCC 19606, C. albicans ATCC 10231, C. krusei ATCC 34135, and ATCC 13803, and C. glabrata ATCC 90030, by using the agar dilution method. The ethanolic extract exhibited the highest level of inhibition against all the tested pathogens except for A. baumannii against which none of the extracts showed inhibitory activity. On the other hand, methanol and dichloromethane extracts showed antimicrobial effects against S. aureus, E. faecalis, C. albicans, C. glabrata, and C. krusei, but not against E. coli, and P. aeruginosa.
L. tigrinus was also investigated for its antioxidant properties. Acetonitrile and hexane extracts showed the DPPH radical scavenging activity of 39.2% (EC50 value 637.75 mg/mL) and 35.5% (EC50 value 710.23 mg/mL), while tested for antioxidant status (TAS), total oxidant status (TOS) and oxidative stress index (OSI) carried out direct on sporophores demonstrated that L. tigrinus TAS, TOS, and OSI values were 1.748 ± 0.071, 19.294 ± 0.237, and 1.106 ± 0.031, respectively [96,97].
For the first time, the anticancer potential of a soluble protein fraction (LTPp) of L. tigrinus was also reported [98]. LTPp exhibited an antiproliferation effect against both MCF-7 and PC3 cancer cell lines, also inducing modification in their morphology. Moreover, LTPp at a concentration of 70 μg/mL was shown to kill approximately 45 and 70% of MCF-7 and PC3 cells, respectively, inducing cell apoptosis.

2.17. Pleurotus cornucopiae (Paulet) Quél.

Pleurotus cornucopiae is a saprophytic basidiomycete belonging to Pleurotace. It is often found on stumps and fallen trunks of oak, elm, and other broad-leaved species. It is widespread in Europe and China, where it is one of the most consumed mushrooms belonging to the genus Pleurotus. In freshwater ecosystems, it is reported as a saprotroph on dead wood of P. alba stumps. Several studies have reported on the medicinal properties of this species [3,5]. In a study conducted by Wang et al. [99], it was isolated from P. cornucopiae and two novel sesquiterpenes named pleurospiroketals A and E showed antioxidant activity, inducing the inhibition of nitric oxide productional lipopolysaccharide-activated macrophages (IC50 values ranging from 6.8 to 20.8 µM). The antioxidant activity of P. cornucopiae was also demonstrated by Zhang et al. [100], who isolated three intracellular zinc polysaccharides from the mushroom. These polysaccharides had action in the upregulation of superoxide dismutase, GSH peroxidase, and catalase, also reducing lipid peroxidation within in vivo tests. Antioxidant properties of P. cornucopiae were also investigated by Landingin et al. [79]. The radical scavenging activity of its ethanolic extract (concentration 1000 ppm) was measured via DPPH assay, recording a value of 41.75%. Tanaka et al. [101] carried out a double-blind, placebo-controlled human clinical trial and demonstrated the ability of P. cornucopiae to regulate the immune system. They evaluated the levels of serum cytokine involved in the regulation of the immune systems and demonstrated that P. cornucopiae, administered for 8 weeks, increased the levels of interferon (IFN-γ) and interleukin IL-12 in serum.
Some medical activities of P. cornucopiae are also related to its laccase production. A novel laccase isolated from broth cultivation of P. cornucopiae exhibited an inhibitory effect against the cancer cell lines HepG2 (hepatoma cells) and MCF-7 (breast cancer cells), with IC50 values of 3.9 and 7.6 µM. Moreover, it showed the inhibition of the activity of HIV-I reverse transcriptase with an IC50 value of 3.7 µM [102].

2.18. Pleurotus ostreatus (Jacq.) P. Kumm.

Pleurotus ostreatus is one of the most common edible mushrooms. It belongs to Pleurotaceae, and it usually can be found as a saprotroph and primary decomposer on deciduous trees, acting as a white rot wood decay fungus; it can also be found in freshwater ecosystems as saprotroph on P. alba stumps. It can grow in many places, and it can also be easily cultivated on straw or other media. Furthermore, it is consumed all over the world, both for its nutritional and medicinal value. This mushroom, indeed, possesses several pharmaceutical properties [3]. P. ostreatus extract showed a stimulatory activity against the catalase gene expression and a reduction in the incidence of free-radical-induced protein oxidation in rats, reducing age-related disorders [103]. Ethanolic extract and carbohydrate components, mainly β-glucans, showed antioxidant activity in vitro and in vivo in superoxide radicals, scavenging hydroxyl, lipid peroxidation, and reducing power on ferrous ions [104,105]. Cao et al. [106] demonstrated that polysaccharides extracted from P. ostreatus mycelium had both in vitro and in vivo antitumor properties against BGC-823 cells (human gastric cell lines), inhibiting the proliferation by 35.6% at a concentration of 400 mg/mL. Using P. ostreatus extracellular filtrate, El Domany et al. [107] synthesized gold nanoparticles to test them against the human cancer cell line HepG2, the prostate cancer cell line PC3, and the human colon cancer cell line HCT-116, demonstrating that P. ostreatus nanoparticles significantly reduced the viability of HepG2 and HCT-116 by 33.5% and 22.7%, respectively. Ethanol extracts of P. ostreatus named CT-WS, CP-WS, CT-LcS, and CP-LcS were tested for their antimicrobial properties against E. coli ATCC 10536, E. coli PeruMycA 2, E. coli PeruMycA3, B. cereus PeruMycA 4, P. aeruginosa PeruMyc 5, B. subtilis PeruMyc 6, Salmonella typhy PeruMyc 7, S. aureus ATCC 6538, C. albicans YEPGA 6183, C. tropicalis YEPGA 6184, C. albicans YEPGA 6379, C. parapsilopsis YEPGA 6551, Arthroderma crocatum CCF 5300, A. curreyi CCF 5207, A. gypseum CCF 6261, A. insingulare CCF 5417, A. quadrifidum CCF 5792, Trichophyton mentagrophytes CCF 4823, T. mentagrophytes CCF 5930, T. rubrum CCF 4933, T. rubrum CCF 4879, and T. tonsurans CCF 4834. All extracts showed antimicrobial effects at MIC values ranging from 6.25 to 200 µg/mL, and the highest levels of inhibition were registered for CT-LcS and CP-LcS against yeast; regarding bacteria, the highest activity was registered for CP-LcS [104]. Methanol extracts of P. ostreatus cultivated on different substrates were tested against E. coli, S. aureus, C. albicans, and Cryptococcus neoformans, showing inhibitory activity against all of them with MIC values ranging from 0.08 mg/mL to 2.5 mg/mL. However, P. ostreatus growing on sugarcane bagasse showed the highest antimicrobial activity against E. coli, also demonstrating that the growth substrate influences fungal medicinal properties [108]. Methanol and ethyl acetate extracts obtained from P. ostreatus sporophores significantly decreased blood glucose levels of streptozotocin-treated diabetic rats after two weeks of treatment by oral administration (200 mg/kg). Moreover, the administration of both methanol and ethyl acetate extract significantly reduced blood levels of total cholesterol by 16.92 and 26%, triglycerides by 17.33 and 29.33%, low-density lipoprotein (LDL) by 17.3 and 20%, while increasing the levels of HDL-cholesterol by 17.94 and 30.76%, respectively [109]. Since one of the strategies for the controlling of diabetes mellitus is to inhibit carbohydrate-digesting enzymes, such as α-amylase and α-glucosidase, the water/ethanol of P. ostreatus was tested for this purpose. Five different concentrations were tested, 50, 100, 150, 200, and 250 μg/mL and the results showed that the percentage of inhibition ranged from 14.65 ± 1.94 to 62.55 ± 1.07% for α-amylase and from 18.35 ± 1.70 to 82.54 ± 0.88% for α-glucosidase, with dose-dependent inhibitory effect [110].

2.19. Schizophyllum commune Fr.

Schizophyllum commune is a saprotroph species belonging to Schizophyllaceae. It usually grows on decaying trees, especially after rainy seasons. In freshwater habitats, it was recorded on the stumps and dead trunks of S. alba and P. alba. Its wide distribution and its pharmaceutical potential make it a globally consumed food supplement, but also an important source for industrial applications and cosmetics [111]. Among the medicinal properties of S. commune, its antioxidant potential, due to the high presence of phenolic compounds, is one of the most investigated [112]. Studies about the influence of raw materials used for S. commune cultivation on its antioxidant activity were examined by Basso et al. [113]. Pine sawdust (PS), grape residue (GR), cotton cake (CC), and jatropha seed cake (JK) were used as substrates of cultivation, and antioxidant activity was evaluated via DPPH radical scavenging assay. The results showed that S. commune samples grown on CC showed the best antioxidant activity (58.15 ± 0.86 DPPH % scavenging), probably due to the highest phenolic content (291.51 ± 1.83 mg GAE/100 g mushroom). Mišković et al. [114] tested submerged cultivated mycelia and fermentation broth of ethanolc and polysaccharide extract from two different S. commune strains (Italian, IT and Serbian, SRB) to determine their acetylcholinesterase (AChE) inhibitors production (important agents against Alzheimer’s), as well as their antioxidant and antibacterial activity. Polysaccharide extracts of SRB strains from submerged cultivated mycelia showed the highest AChE activity with IC50 values of 79.73 ± 26.34 µg/mL after 28 days of fermentation and significant antioxidant activity. Only two extracts showed antibacterial activity, and both came from the SRB strain. In particular, the highest antimicrobial activity was registered for the sporophores extract MIC and MBC value < 0.31%) against E. coli, B. cereus, and S. aureus. Hexane, chloroform, ethyl acetate methanol, and hot water extracts of S. commune were evaluated for their scavenging activity. On the other hand, crude polysaccharide was tested for hepatoprotective activity on human hepatoma-cells (HepG2) after hydrogen peroxide-induced toxicity. All the extracts showed DPPH radical scavenging activity with IC50 values of 0.57 ± 0.02 mg/mL, 0.40 ± 0.01 mg/mL, 0.36 ± 0.00 mg/mL, 0.32 ± 0.00 mg/mL, and 1.00 ± 0.05 mg/mL, respectively, showing a positive correlation between DPPH scavenging activity and the content of phenols and flavonoids. Regarding hepatoprotective activity, polysaccharide extract inhibited lipid peroxidation while increasing glutathione levels against hydrogen peroxide-induced damage [115]. Al-Azad and Ping [116] tested the antioxidant and antibacterial activity of aqueous, methanol, ethanol, and acetone extracts of S. commune. The antioxidant activity was tested by DPPH assay in which ethanol extract showed the highest scavenging activity (97.19%). The antimicrobial activity was verified in the three marine bacteria Vibrio harveyi, V. parahaemolyticus, and V. anguillarum by MIC determination. All the extracts showed the highest inhibitory activity against V. harveyi with MIC value lower than 1.25 mg/mL, while inhibitory activity were registered at MIC values of 2.5 mg/mL and 5 mg/mL for V. parahaemolyticus and at 5 mg/mL for V. anguilarium.

2.20. Penicillium aculeatum Raper and Fennell

Penicillium aculeatum is a mold belonging to Trichocomaceae. Very little information has been reported in the literature about it and its ecological role: in freshwater environments, it was isolated as an endophyte from the leaves and roots of Phragmites australis. This mold is significant in the production of pigments and other molecules with pharmaceutical properties. The broth and the mycelial ethyl acetate extract of P. aculeatum showed antimicrobial activity against S. aureus ATCC 25923 (MIC value of 200 and 128 µg/mL, respectively). Only the second one showed antimicrobial activity also against Criptococcus neoformans ATCC 90113 (MIC value 200 µg/mL). Moreover, it also has cytotoxic activity against KB cell lines (oral cavity cancer cell lines) with an IC50 value of 27.56 µg/mL. Antimicrobial activity was registered for mycelial hexane extract against C. neoformans and Mycobacterium tuberculosis H37Ra (MIC values of 200 and 50 µg/mL, respectively), together with the antimalarial effect, and the cytotoxic effect against KB and MCF-7 (IC50 values of 3.75, 21.14, and 35.74 µg/mL, respectively). In addition, nine secondary metabolites were isolated from the broth extract, and some of them exhibited antimicrobial and cytotoxic activity. In particular, penipurdin A showed an inhibitory effect against M. tuberculosis with an MIC value of 25 µg/mL. Altenusin showed a moderate inhibitory effect against S. aureus with an MIC value of 32 µg/mL and a moderate cytotoxic effect against African green monkey kidney fibroblast [117]. The ankaflavin, a pigment extracted from P. aculeatum, was tested for cytotoxic activity against MCF-7, HCT116, and PC-3 cell lines. While it showed very limited toxicity against MCF-7, significant results were obtained against HCT116 and PC-3 cell lines with IC50 values of 162 µg/mL and 85 µg/mL, respectively [118]. Hawas et al. [119] isolated two new sulfonyl metabolites from the ethyl acetate extract of P. aculeatum called pensulfonoxy and pensulfonamide. Ethyl acetate extract showed antibacterial activity against E. coli (diameter of inhibition zone of 20.5 mm), while pensulfonamide showed not only an inhibitory effect against C. albicans (diameter of inhibition zone of 18 mm) but also potent cytotoxicity against MCF-7 cell line (IC50 2.18 µM). In contrast, pensulfoxony only showed a mild cytotoxic effect against the HTC-116 cell line (IC50 5.23 µM).

2.21. Penicillium chrysogenum Thom

P. chrysogenum is a micormycetes belonging to Thricomaceae. It is commonly found in temperate and subtropical regions both in soil and in dead plant material, and it is also known as a post-harvest contaminant of fruit, vegetables, and grains. In freshwater ecosystems, it was associated as endophyte with roots of P. australis. P. chrysogenum represents one of the most studied species of the genus Penicillium for its capability to produce penicillin and other antibiotic compounds [120]. Holzknecht et al. [121] reported the anti-Candida properties of the antifungal protein C (PAFC) extracted from P. chrysogenum that was able to kill the planktonic cell and reduce the metabolic activity of sessile cells in the biofilms of two different strains of C. albicans. Orfali et al. [122] tested the antimicrobial activity of several dihydroisocumarins isolated from P. chrysogenum against the pathogenic bacteria S. aureus, B. licheniformis, Escherichia fergusonii, Enterobacter xiangfagensis, and P. aeruginosa. These compounds showed high antibacterial activity against S. aureus and B. licheniformis with MIC values ranging from 0.8 to 21.6 μg/mL. Recent studies reported the cytotoxic potential of P. chrysogenum. Niu et al. [123] tested different compounds isolated from P. chrysogenum against BEL-7402, BIU-87, ECA109, Hela-S3, and PANC-1 cell lines. Among the tested compounds, Peniciversiol A showed significant cytotoxic effects against BIO-87 cells (IC50 value 10.21 μM). Penicilactones A-B, Decumbenone A-B, Aspermutarubrol 3-hydroxy-5-(3-hydroxy-5-methylphenoxy)benzoic acid, Cyclopenol, and Violaceol-II showed cytotoxic activity against BEL-7402, BIU-87, and ECA109 cancer cell lines (IC50 values ranging from 7.70 to 20 μM). The anticancer effect of taxol produced by P. chrysogenum was tested against several cell lines such as liver cancer cells (HEPG2) and breast adenocarcinoma (MCF7) cells. Results showed that the viability of both cancer cell lines decreased in a dose-dependent manner with an IC50 values of 3.7 and 3.3 μM for HEPG2 and MCF7, respectively [124]. Penichryfuran A exhibited high cytotoxicity against the HepG2 cell line with an IC50 value of 9.0 μM. The ethyl acetate extract of P. chrysogenum and Kojic acid showed strong activity against HEP-2 larynx carcinoma cells, with IC50 22.6 ± 0.8 and 23.4 ± 1.4 µg/mL, respectively [125,126]. According to Al-Saleem et al. [126], Kojicacid showed a potent antioxidant activity with IC50m33.7 ± 0.8 µg/mL as revealed by the DPPH free radical-scavenging technique.

2.22. Fusarium incarnatum (Desm.) Sacc.

Fusarium incarnatum is a pathogenic mold belonging to Nectriaceae. It is widespread in subtropical and temperate regions as the agent of several crop diseases and mycotoxin producers such as trichothecenes and zearalenone [127]. In freshwater habitats, it was isolated as an endophyte from the roots and leaves of P. australis. Very little research has been reported on the medicinal properties of F. incarnatum. The ethyl acetate extract of F. incarnatum was tested by Das et al. [128] for its antioxidant and antibacterial properties. The fungal extract showed high radical scavenging activity both in ABTS (17.5 ± 0.2 mg TE/g dry extract) and the DPPH assay (IC50 value 379.98 ± 0.8 μg/mL); high reducing power (38.3 ± 0.6 mg AA/g dry extract) and high inhibition capacity of lipid peroxidation (IC50 534.69 ± 2.7 μg/mL). Regarding the antimicrobial effect, it showed inhibition properties against P. aeruginosa, S. aureus, E. coli, Enterobacter aerogenes, and K. pneumoniae with a diameter of inhibition zone of 15.0 ± 0.9, 12.5 ± 0.5, 16.9 ± 0.2, 15.6 ± 0.7, 10.0 ± 0.1 mm, respectively. Chua et al., 2024 [129] separated bioactive compounds with antimicrobial activity from the crude extract of F. incarnatum, showing that Fraction 1 and Fraction 2, rich in alkaloids, terpenoids, flavonoids, and phenolic compounds, had an inhibitory effect against B. cereus and Ganoderma boninense Pat. with MIC values of 0.156 and 0.3125 mg/mL, respectively.

3. Conclusions

This review demonstrated that freshwater fungi possess significant medicinal potential. As reported in Figure 2, most of them are known to have antioxidant properties, acting against free radical and cellular oxidation processes, and antimicrobial activity against several pathogenic bacteria and fungi of clinical importance. Among the medicinal properties, antiaging effect, antidiabetic potential, anti-inflammatory, immunomodulatory, hepatoprotective, cardioprotective, anticancer, anti-Alzheimer, and antihypercholesterolemic activities were also reported, confirming that this ecological fungal group represents not only an important part of the wide fungal diversity but also a valid alternative source of bioactive compounds useful for human and animal health.

Author Contributions

Conceptualization, G.V., I.C., and G.M.; methodology, G.M.; validation, G.V.; investigation, G.M.; resources, G.M.; data curation, I.C. and G.M.; writing—original draft preparation, G.M.; writing—review and editing, I.C. and G.V.; visualization, G.M.; supervision, G.V.; project administration, G.V.; funding acquisition, G.V. All authors have read and agreed to the published version of the manuscript.

Funding

Project funded under the National Recovery and Resilience Plan (NRRP), Mission 4, Component 2, Investment 1.4-Call for tender No. 3138 of 16 December 2021, rectified by Decree n. 3175 of 18 December 2021 of Italian Ministry of University and Research funded by the European Union—NextGenerationEU Project Code CN_00000033, Concession Decree No. 1034 of 17 June 2022 adopted by the Italian Ministry of University and Research, CUP B73C22000790001, Project Title “National Biodiversity Future Center-NBFC”.

Data Availability Statement

No new data were created or analyzed in this study.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Wasser, S.P. Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Appl. Microbiol. Biotechnol. 2011, 89, 1323–1332. [Google Scholar] [CrossRef] [PubMed]
  2. Gargano, M.L.; van Griensven, L.J.L.D.; Isikhuemhen, O.S.; Lindequist, U.; Venturella, G.; Wasser, S.P.; Zervakis, G.I. Medicinal mushrooms: Valuable biological resources of high exploitation potential (Review). Plant Biosyst. 2017, 151, 548–565. [Google Scholar] [CrossRef]
  3. Venturella, G.; Ferraro, V.; Cirlincione, F.; Gargano, M. Medicinal mushrooms: Bioactive compounds, use, and clinical trials. Int. J. Mol. Sci. 2021, 22, 634. [Google Scholar] [CrossRef] [PubMed]
  4. Panda, S.K.; Luyten, W. Medicinal mushrooms: Clinical perspective and challenges. Drug Discov. Today 2022, 27, 636–651. [Google Scholar] [CrossRef] [PubMed]
  5. Cateni, F.; Gargano, M.L.; Procida, G.; Venturella, G.; Cirlincione, F.; Ferraro, V. Mycochemicals in wild and cultivated mushrooms: Nutrition and health. Phytochem. Rev. 2022, 21, 339–383. [Google Scholar] [CrossRef]
  6. Herman, K.C.; Bleichrodt, R. Go with the flow: Mechanisms driving water transport during vegetative growth and fruiting. Fungal Biol. Rev. 2022, 41, 10–23. [Google Scholar] [CrossRef]
  7. Jones, E.B.G.; Hyde, K.D.; Pang, K.L. Freshwater Fungi and Fungal Like Organisms, 1st ed.; Dd Grutyer GmbH: Berlin, Germany, 2014; p. 510. [Google Scholar]
  8. Gulis, V.; Su, R.; Kuehn, K.A. Fungal decomposers in freshwater environments. In The Structure and Function of Aquatic Microbial Communities; Hurts, C., Ed.; Advances in Environmental Microbiology; Springer: Cham, Switzerland, 2019; Volume 7, pp. 121–155. [Google Scholar]
  9. Mirabile, G.; Ferraro, V.; Mancuso, F.P.; Pecoraro, L.; Cirlincione, F. Biodiversity of fungi in freshwater ecosystems of Italy. J. Fungi 2023, 9, 993. [Google Scholar] [CrossRef]
  10. Angelini, P.; Rubini, A.; Gigante, D.; Reale, L.; Pagiotti, R.; Venanzoni, R. The endophytic fungal communities associated with the leaves and roots of the common red (Phragmites australis) in Lake Trasimeno (Perugia, Italy) in declining and healthy stands. Fungal Ecol. 2012, 5, 683–693. [Google Scholar] [CrossRef]
  11. Giri, S.; Biswas, G.; Pradhan, P.; Mandal, S.C.; Acharya, K. Antimicrobial activities of basidiocarps of wild edible mushrooms of West Bengal, India. Int. J. Pharmtech Res. 2012, 4, 1554–1560. [Google Scholar]
  12. Paloi, S.; Acharya, K. Antioxidant activities and bioactive compounds of polyphenol rich extract from Amanita vaginata (Bull.) Lam. Int. J. Pharmtech Res. 2013, 5, 1645–1654. [Google Scholar]
  13. Paloi, S.; Acharya, K. Evaluation of antioxidative activity and chemical composition of ethanolic extract from Amanita vaginata (bull.) Lam.: An in vitro study. Asian J. Pharm. Clin. Res. 2014, 7, 88–92. [Google Scholar]
  14. Muszyńska, B.; Sułkowska-Ziaja, K.; Wołkowska, M.; Ekiert, H. Chemical, pharmacological and biological characterization of the culinary-medicinal honey mushroom, Armillaria mellea (Vahl) P. Kumm. (Agaricomycetidae): A review. Int. J. Med. Mushrooms 2011, 13, 167–175. [Google Scholar] [CrossRef]
  15. Chen, X.; Liu, Y.; Ren, L.; Dai, X.; Zhao, J.; Gao, C.; Zhang, S.; Dong, J.; Zhao, Z.; Li, Y.; et al. Extraction, purification, structural characteristics and biological properties of the polysaccharides from Armillaria mellea (Vahl) P. Kumm.: A review. Int. J. Biol. Macromol. 2024, 259, 129175. [Google Scholar] [CrossRef]
  16. Lung, M.-Y.; Chang, Y.-C. Antioxidant properties of the edible Basidiomycete Armillaria mellea in submerged cultures. Int. J. Mol. Sci. 2011, 12, 6367–6384. [Google Scholar] [CrossRef]
  17. Erbiai, E.H.; da Silva, L.P.; Saidi, R.; Lamrani, Z.; Esteves da Silva, J.C.G.; Maouni, A. Chemical composition, bioactive compounds, and antioxidant activity of two wild edible mushrooms Armillaria mellea and Macrolepiota procera from two countries (Morocco and Portugal). Biomolecules 2021, 11, 575. [Google Scholar] [CrossRef] [PubMed]
  18. An, S.; Lu, W.; Zhang, Y.; Yuan, Q.; Wang, D. Pharmacological basis for use of Armillaria mellea polysaccharides in Alzheimer’s disease: Antiapoptosis and antioxidation. Oxid. Med. Cell. Longev. 2017, 2017, 4184562. [Google Scholar] [CrossRef]
  19. Kostić, M.; Smiljković, M.; Petrović, J.; Glamočlija, J.; Barros, L.; Ferreira, I.C.F.R.; Ćirić, A.; Soković, M. Chemical, nutritive composition and a wide range of bioactive properties of honey mushroom Armillaria mellea (Vahl: Fr.) Kummer. Food Funct. 2017, 8, 3239. [Google Scholar] [CrossRef]
  20. Ren, S.; Gao, Y.; Li, H.; Ma, H.; Han, X.; Yang, Z.; Chen, W. Research status and application prospects of the medicinal mushroom Armillaria mellea. Appl. Biochem. Biotechnol. 2023, 195, 3491–3507. [Google Scholar] [CrossRef]
  21. Chang, W.H.; Huang, H.L.; Huang, W.P.; Chen, C.C.; Chen, Y.J. Armillaridin induces autophagy-associated cell death in human chronic myelogenous leukemia K562 cells. Tumor Biol. 2016, 37, 14291–14300. [Google Scholar] [CrossRef]
  22. Chen, Y.J.; Chen, C.C.; Huang, H.L. Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma. Onco Targets Ther. 2016, 9, 4773. [Google Scholar]
  23. Li, Z.; Wang, Y.; Jiang, B.; Li, W.; Zheng, L.; Yang, X.; Bao, Y.; Sun, L.; Yan, X.; Huang, Y.; et al. Structure, cytotoxic activity and mechanism of protoilludane sesquiterpene aryl esters from the mycelium of Armillaria mellea. J. Ethnopharmacol. 2016, 184, 119–127. [Google Scholar] [CrossRef] [PubMed]
  24. Schnabel, G.; Ash, J.; Bryson, P. Identification and characterization of Armillaria tabescens from the southeastern United States. Br. Mycol. Soc. 2005, 109, 1208–1222. [Google Scholar] [CrossRef]
  25. Herath, H.M.T.B.; Jacob, M.; Wilson, A.D.; Abbas, H.K.; Nanayakkara, N.P.D. New compounds and secondary metabolites from bioactive extracts of the fungus Armillaria tabescens. Nat. Prod. Res. 2013, 27, 1562–1568. [Google Scholar] [CrossRef] [PubMed]
  26. Tel, G.; Deveci, E.; Küçükaydın, S.; Özler, M.A.; Duru, M.E.; Harmandar, M. Evaluation of antioxidant activity of Armillaria tabescens, Leucopaxillus gentianeus and Suillus granulatus: The mushroom species from Anatolia. Eurasian J. Anal. Chem. 2013, 8, 136–147. [Google Scholar]
  27. Shajahan, M.D.; Samaipati, N. Ectomycorrhizal fungi of Shorea robusta G.f. from West Bengal. J. Mycopathol Res. 1995, 33, 105–117. [Google Scholar]
  28. Phosri, C.; Watling, R.; Martin, M.P.; Whalley, A.J.S. The genus Astraeus in Thailand. Mycotaxon 2004, 89, 453–463. [Google Scholar]
  29. Pavithra, M.; Sridhar, K.R.; Greeshma, A.A.; Tomita-Yokotani, K. Bioactive potential of the wild mushroom Astraeus hygrometricus in South-west India. Mycology 2016, 7, 191–202. [Google Scholar] [CrossRef] [PubMed]
  30. Singh, P.; Varshney, V.K. Nutritional attributes and nonvolatile taste components of medicinally important wild false earthstar murhsroom, Astraeus hygrometricus (Agaricomycetes), from India. Int. J. Med. Mushrooms 2020, 22, 909–918. [Google Scholar] [CrossRef] [PubMed]
  31. Takaishi, Y.; Murakami, Y.; Ohashi, T.; Nakano, K.; Murakami, K.; Tomimatsu, T. Three triterpenes from Astraeus hygrometricus. Phytochemistry 1987, 26, 2341–2344. [Google Scholar] [CrossRef]
  32. Pramanik, A.; Islam, S.S. Structural studies of a polysaccharide isolated from an edible mushroom, Astraeus hygrometricus. Indian J. Chem. 2000, 39, 525–529. [Google Scholar]
  33. Yagi, F.; Sakai, T.; Shiraishi, N.; Yotsumot, M.; Mukoyoshi, R. Hemagglutinins (lectins) in fruit bodies of Japanese higher fungi. Mycoscience 2000, 41, 323–330. [Google Scholar] [CrossRef]
  34. Maiti, D.; Chandra, K.; Mondal, S.; Ojha, A.K.; Das, D.; Roy, S.K.; Gosh, K.; Chakraborty, I.; Islam, S.S. Isolation and characterization of a heteroglycan from the fruits of Astraeus hygrometricus. Carbohydr. Res. 2008, 343, 817–824. [Google Scholar] [CrossRef] [PubMed]
  35. Lai, T.K.; Biswas, G.; Chatterjee, S.; Dutta, A.; Pal, C.; Banerji, J.; Bhuvanesh, N.; Reibenspies, J.H.; Acharya, K. Leishmanicidal and anticandidal activity of constituents of Indian edible mushroom Astraeus hygrometricus. Chem. Biodivers. 2012, 9, 1517–1524. [Google Scholar] [CrossRef]
  36. Biswas, G.; Chatterjee, S.; Sarkar, S.; Acharya, K. Evaluation of antioxidant and nitric oxide synthase activation properties of Astraeus hygrometricus (Pers.) Morg. Int. J. Biom. Pharm. Sci. 2010, 4, 21–26. [Google Scholar]
  37. Biswas, G.; Nandi, S.; Kuila, D.; Acharya, K. A comprehensive review on food and medicinal prospects of Astraeus hygrometricus. Pharm. J. 2017, 9, 799–806. [Google Scholar] [CrossRef]
  38. Mallick, S.; Dutta, A.; Dey, S.; Ghosh, J.; Mukherjee, D.; Sultana, S.S.; Mandal, S.; Paloi, S.; Khatua, S.; Acharya, K.; et al. Selective inhibition of Leishmania donovani by active extracts of wild mushrooms used by the tribal population of India: An in vitro exploration for new leads against parasitic protozoans. Exp. Parasitol. 2014, 138, 9–17. [Google Scholar] [CrossRef] [PubMed]
  39. Mallick, S.; Dey, S.; Mandal, S.; Dutta, A.; Mukherjee, D.; Biswas, G.; Chatterjee, S.; Mallick, S.K.; Lai, T.K.; Acharya, K.; et al. A novel triterpene from Astraeus hygrometricus induces reactive oxygen species leading to death in Leishmania donovani. Future Microbiol. 2015, 10, 763–789. [Google Scholar] [CrossRef] [PubMed]
  40. Mallick, S.; Dutta, A.; Chaudhuri, A.; Mukherjee, D.; Dey, S.; Halder, S.; Gosh, J.; Mukherjee, D.; Sultana, S.S.; Biswas, G.; et al. Successful therapy of murine visceral leishmaniasis with astrakurkurone, a triterpene isolated from the mushroom Astraeus hygrometricus, involves the induction of protective cell-mediated immunity and TLR9. Antimicrob. Agents Chemother. 2016, 60, 2696–2708. [Google Scholar] [CrossRef]
  41. Biswas, G.; Rana, S.; Sarkar, S.; Acharya, K. Cardioprotective activity of ethanolic extract of Astraeus hygrometricus (pers) morg. Pharmacologyonline 2011, 2, 808–817. [Google Scholar]
  42. Biswas, G.; Sarkar, S.; Acharya, K. Hepatoprotective activity of the ethanolic extract of Astraeus hygrometricus (pers) morg. Dig. J. Nanomater. Biostruct. 2011, 6, 637–641. [Google Scholar]
  43. Biswas, G.; Acharya, K. Hypoglycemic activity of ethanolic extract of Astraeus hygrometricus (pers) morg. in alloxan-induced diabetic mice. Int. J. Pharm. Sci. 2013, 5, 391–394. [Google Scholar]
  44. Chakraborty, I.; Mondal, S.; Pramanik, M.; Rout, D.; Islam, S.S. Structural investigation of a water-soluble glucan from an edible mushroom, Astraeus hygrometricus. Carbohydr. Res. 2004, 339, 2249–2254. [Google Scholar] [CrossRef]
  45. Chakraborty, I.; Mondal, S.; Rout, D.; Chandra, K.; Islam, S.S. Structural investigation of a heteroglycan isolated from the fruit bodies of an ectomycorrhizal fungus Astraeus hygrometricus. Carbohydr. Res. 2007, 342, 982–987. [Google Scholar] [CrossRef] [PubMed]
  46. Mallick, S.K.; Bhutia, S.K.; Maiti, T.K. Macrophage stimulation by polysaccharides isolated from barometer earthstar mushroom, Astraeus hygrometricus (Pers) Morgan (Gasteromycetideae). Int. J. Med. Mushrooms 2009, 11, 237–248. [Google Scholar] [CrossRef]
  47. Krout, J.; Wu, F. Revealing the cryptic diversity of wood-inhabiting Auricularia (Auriculariales, Basidiomycota) in Europe. Forest 2022, 13, 532. [Google Scholar]
  48. Cai, M.; Lin, Y.; Luo, Y.L.; Liang, H.H.; Sun, P. Extraction, antimicrobial, and antioxidant activities of crude polysaccharides from the wood ear medicinal mushroom Auricularia auricula-judae (higher basidiomycetes). Int. J. Med. Mushrooms 2015, 17, 591–600. [Google Scholar] [CrossRef] [PubMed]
  49. Zhang, Y.; Zeng, Y.; Men, Y.; Zhang, J.; Liu, H.; Sun, Y. Structural characterization and immunomodulatory activity of exopolysaccharides from submerged culture of Auricularia auricula-judae. Int. J. Biol. Macromol. 2018, 115, 978–984. [Google Scholar] [CrossRef] [PubMed]
  50. Liu, E.; Ji, Y.; Zhang, F.; Liu, B.; Meng, X. Review on Auricularia auricula-judae as a functional food: Growth, chemical composition, and biological activities. J. Agric. Food Chem. 2021, 69, 1739–1750. [Google Scholar] [CrossRef] [PubMed]
  51. Oli, A.N.; Edeh, P.A.; Al-Mosawi, R.M.; Mbachu, N.A.; Al-Dahmoshi, H.O.M.; Al-Khafaji, N.S.K.; Ekuma, U.O.; Saki, M. Evaluation of the phytoconstituents of Auricularia auricula-judae mushroom and antimicrobial activity of its protein extract. Eur. J. Integr. Med. 2020, 38, 101176. [Google Scholar] [CrossRef]
  52. Yoon, S.J.; Yu, M.A.; Pyun, Y.R.; Hwang, J.K.; Chu, D.C.; Juneja, L.R.; Mourão, P.A.S. The nontoxic mushroom Auricularia auricula contains a polysaccharide with anticoagulant activity mediated by antithrombin. Thromb. Res. 2003, 112, 151–158. [Google Scholar] [CrossRef]
  53. Islam, T.; Ganesan, K.; Xu, B.J. New insight into mycochemical profiles and antioxidant activities of legumes as affected by extraction solvents. J. Food. Sci. 2019, 72, S159–S166. [Google Scholar]
  54. Mapoung, S.; Umsumarng, S.; Semmarath, W.; Arjsri, P.; Thippraphan, P.; Yodkeeree, S.; Limtrakul, P. Skin wound-healing potential of polysaccharides from medicinal mushroom Auricularia auricula-judae (Bull.). J. Fungi 2021, 7, 247. [Google Scholar] [CrossRef] [PubMed]
  55. Heinfling, A.; Martínez, M.J.; Martínez, A.T.; Bergbauer, M.; Szewzyk, U. Purification and characterization of peroxidases from the dye-decolorizing fungus Bjerkandera adusta. FEMS Microbiol. Lett. 1998, 165, 43–50. [Google Scholar] [CrossRef] [PubMed]
  56. Eichlerová, I.; Homolka, L.; Nerud, F. Decolorization of high concentration of synthetic dyes by the white rot fungus Bjerkandera adusta strain CCBAS 232. Dyes Pigments 2007, 75, 38–44. [Google Scholar] [CrossRef]
  57. Olennikov, D.; Agafonova, S.; Penzina, T.; Borovskii, G. Fatty acid composition of fourteen wood-decaying basidiomycete species growing in permafrost conditions. Rec. Nat. Prod. 2014, 8, 184–188. [Google Scholar]
  58. Soliman, E.R.S.; El-Sayed, H. Molecular identification and antimicrobial activities of some wild Egyptian mushrooms: Bjerkandera adusta as a promising source of bioactive antimicrobial phenolic compounds. J. Gen. Eng. Biotechnol. 2021, 19, 1–11. [Google Scholar] [CrossRef] [PubMed]
  59. de Oliveira, C.F.; Rech, K.S.; Moura, P.F.; Oliveira, C.S.P.; Hirota, B.C.K.; Betim, F.C.M.; Balbi, M.E.; Zanin, S.M.W.; Dias, J.F.G.; Miguel, O.G.; et al. Evaluation of the nutritional composition and antioxidant activity of Bjerkandera adusta. Braz. J. Pharm. Sci. 2022, 58, e20312. [Google Scholar] [CrossRef]
  60. Altuner, E.M.; Akata, I.; Canli, K. In vitro antimicrobial activity screening of Bovista nigrescens Pers. Kastamonu Univ. J. Forest. Fac. 2012, 12, 90–96. [Google Scholar]
  61. Bal, C.; Eraslan, E.C.; Sevindik, M. Antioxidant, antimicrobial activities, total phenolic and element contents of wild edible mushroom Bovista nigrescens. Prospect Pharm. Sci. 2023, 21, 37–41. [Google Scholar] [CrossRef]
  62. Vishwakarma, P.; Singh, P.; Tripathi, N.N. Nutritional and antioxidant properties of wild edible macrofungi from North-Eastern Uttar Pradesh, India. IJTK 2016, 15, 143–148. [Google Scholar]
  63. Radović, J.; Leković, A.; Damjanović, A.; Kopanja, Đ.; Dodevska, M.; Stanojković, T.; Marinković, T.; Jelić, Č.; Kundaković-Vasović, T. St. George’s mushroom, Calocybe gambosa (Fr.) Donk: A promising source of nutrients and biologically active compounds. Acta Aliment. 2022, 51, 134–144. [Google Scholar] [CrossRef]
  64. Petrovic, N.; Kosanic, M.; Tosti, T.; Srbljak, I.; Đurić, A. Chemical characterization and bioactive properties of edible and medicinal honey mushroom Armillaria mellea (Agaricomycetes) from Serbia. Int. J. Med. Mushrooms 2022, 25, 1–15. [Google Scholar] [CrossRef] [PubMed]
  65. Al-Habib, M.N.; Holliday, J.; Ţura, D. The pale brittle stem mushroom, Psathyrella candolleana (higher basidiomycetes): An indigenous medicinal mushroom new to Iraq. Int. J. Med. Mushrooms 2014, 16, 617–622. [Google Scholar] [CrossRef] [PubMed]
  66. Liu, Y.P.; Dai, Q.; Wang, W.X.; He, J.; Li, Z.H.; Feng, T.; Liu, J.K. Psathyrins: Antibacterial diterpenoids from Psathyrella candolleana. J. Nat. Prod. 2020, 83, 1725–1729. [Google Scholar] [CrossRef] [PubMed]
  67. Ali, D.; Arooj, N.; Muneer, I.; Bashir, F.; Hanif, M.; Ali, S. Suistainable synthesis of ZnO nanoparticles from Psathyrella candolleana mushroom extract: Characterization, antibacterial activity, and photocatalytic potential. Inorg. Chem. Commun. 2023, 158, 111588. [Google Scholar] [CrossRef]
  68. Zhao, T.D.; Yang, X.Q.; Zhou, J.; Yang, Y.B.; Ding, Z.T. Antibiotic guacastane diterpenoids with two new skeletons from Psathyrella candolleana uncovered by semisolid and liquid media. J. Agric. Food Chem. 2023, 71, 2006–2013. [Google Scholar] [CrossRef] [PubMed]
  69. Pacheco-Sánchez, M.; Boutin, Y.; Angers, P.; Gosselin, A.; Tweddel, R.J. Inhibitory effect of CDP, a polysaccharide extracted from the mushroom Collybia dryophila, on nitric oxide synthase expression and nitric oxide production in macrophages. Eur. J. Pharmacol. 2007, 555, 61–66. [Google Scholar] [CrossRef] [PubMed]
  70. Fan, J.M.; Zhang, J.S.; Tang, Q.J.; Liu, Y.; Zhang, A.Q.; Pan, Y.J. Structural elucidation of a neutral fucogalactan from the mycelium of Coprinus comatus. Carbohydr. Res. 2006, 341, 1130–1134. [Google Scholar] [CrossRef] [PubMed]
  71. Dotan, N.; Wasser, S.P.; Mahajna, J. The culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator. Integr. Cancer Ther. 2011, 10, 148–159. [Google Scholar] [CrossRef]
  72. Zhang, P.; Li, K.; Yang, G.; Xia, C.; Polston, J.E.; Li, G.; Li, S.; Lin, Z.; Yang, L.J.; Bruner, S.D.; et al. Cytotoxic protein from the mushroom Coprinus comatus possesses a unique mode for glycan binding and specificity. Proc. Natl. Acad. Sci. USA 2017, 114, 8980–8985. [Google Scholar] [CrossRef]
  73. Liu, Y.; Zhao, Y.; Yang, Y.; Tang, Q.; Zhou, S.; Wu, D.; Zhang, J. Structural characteristics and hypoglycemic activity of polysaccharides from Coprinus comatus. Bioact. Carbohydr. Diet. Fibre 2013, 2, 164–169. [Google Scholar] [CrossRef]
  74. Gao, Z.; Kong, D.; Cai, W.; Zhang, J.; Jia, L. Characterization and anti-diabetic nephropathic ability of mycelium polysaccharides from Coprinus comatus. Carbohydr. Polym. 2021, 251, 117081. [Google Scholar] [CrossRef] [PubMed]
  75. Ratnaningtyas, N.; Hernayanti, H.; Ekowati, N.; Husen, F. Ethanol extract of the mushroom Coprinus comatus exhibits antidiabetic and antioxidant activities in streptozotocin-induced diabetic rats. Pharm. Biol. 2022, 60, 1126–1136. [Google Scholar] [CrossRef]
  76. Stilinović, N.; Čapo, I.; Vukmirović, S.; Rašković, A.; Tomas, A.; Popović, M.; Sabo, A. Chemical composition, nutritional profile andinvivoantioxidant properties of the cultivated mushroom Coprinus comatus. R. Soc. Open Sci. 2020, 7, 200900. [Google Scholar] [CrossRef] [PubMed]
  77. Sevindik, M.; Akgül, H.; Bal, C.; Selamoglu, Z. Phenolic contents, oxidant/antioxidant potential and heavy metal levels in Cyclocybe cylindracea. Indian J. Pharm. Educ. Res. 2018, 52, 437–441. [Google Scholar] [CrossRef]
  78. Krüzselyi, D.; Vetter, J.; Ott, P.G.; Darcsi, A.; Béni, S.; Gömöry, Á.; Drahos, L.; Zsila, F.; Móricz, Á.M. Isolation and structural elucidation of a novel brunnein-type antioxidant β-carboline alkaloid from Cyclocybe cylindracea. Fitoterapia 2019, 137, 104180. [Google Scholar] [CrossRef]
  79. Landingin, H.R.R.; Francisco, B.E.; Dulay, R.M.R.; Kalaw, S.P.; Reyes, R.G. Mycochemical screening, proximate nutritive composition and radical scavenging activity of Cyclocybe cylindracea and Pleurotus cornucopiae. Curr. Res. Environ. Appl. Mycol. 2021, 11, 37–50. [Google Scholar] [CrossRef]
  80. Sumi, I.; Geetha, D. Physiological and cultural studies on blue oyster mushroom Hypsizygus ulmarius (Bull.:Fr.). Inter. J. Appli. Puresci. Agricult. 2016, 2, 33–38. [Google Scholar]
  81. Al-Faqeeh, L.A.S.; Kagne, S.R.; Naser, M.R. Medical properties of Hypsizygus ulmarius (Bull.). World J. Pharm. Res. 2018, 7, 1077–1085. [Google Scholar]
  82. Greeshma, P.; Ravikumar, K.S.; Neethu, M.N.; Pandey, M.; Zuhara, K.F.; Janardhanan, K.K. Antioxidant, anti-Inflammatory, and antitumor activities of cultured mycelia and fruiting bodies of the Elm Oyster Mushroom, Hypsizygus ulmarius (Agaricomycetes). Int. J. Med. Mushrooms 2016, 18, 235–244. [Google Scholar] [CrossRef]
  83. Govindan, S.; Jayabal, A.; Shanmugam, J.; Romani, P. Antioxidant and hepatoprotective effects of Hypsizygus ulmarius polysaccharide on alcoholic liver injury in rats. Food Sci. Hum. Wellness 2021, 10, 523–535. [Google Scholar] [CrossRef]
  84. Thimmaraju, A.; Govindan, S. Novel studies of characterization, antioxidant, anticoagulant and anticancer activity of purified polysaccharide from Hypsizygus ulmarius mushroom. Bioact. Carbohydr. Diet. Fibre 2022, 27, 100308. [Google Scholar] [CrossRef]
  85. Thimmaraju, A.; Govindan, S.; Rajendran, A.; Ramani, P.; Pateiro, M.; Lorenzo, J.M. Enhancement of physicochemical properties, antioxidant, antitumor, and anticoagulant activities via acetylation of Hypsizygus ulmarius polysaccharide. Int. J. Food Sci. Tech. 2023, 58, 3478–3487. [Google Scholar] [CrossRef]
  86. Thimmaraju, A.; Seedevi, P. Purification, chemical, structural characterization and biological activity of polysaccharide from blue oyster mushroom Hypsizygus ulmarius. Biomass Convers. Biorefinery 2023, 14, 19889–19899. [Google Scholar] [CrossRef]
  87. Wu, S.H.; Dai, Y.C.; Hattori, T.; Yu, T.W.; Wang, D.M.; Parmasto, É.K.; Chang, H.Y.; Shis, S.Y. Species clarification for the medicinally valuable “sanghuang” mushroom. Bot. Stud. 2012, 53, 135–149. [Google Scholar]
  88. Yang, S.; Bao, H.; Wang, H. Chemical components and anti-tumour compounds from Inonotus hispidus. Mycosistema 2019, 38, 127–133. [Google Scholar]
  89. Yang, S.; Bao, H.; Wang, H.; Li, Q. Anti-tumour effect and pharmacokinetics of an active ingredient isolated from Inonotus hispidus. Biol. Pharm. Bull. 2019, 42, 10–17. [Google Scholar] [CrossRef]
  90. Tang, S.J.; Shen, D.A.; Shao, C.X.; Jun, X.U.; Yang, Y.; Jin, L.; Wu, S.L. Classification and identification of a wild Inonotus hispidus and the antitumor activity of the fermentation supernatant. J. South. Agric. 2019, 50, 1671–1679. [Google Scholar]
  91. Angelini, P.; Girometta, C.; Tirillini, B.; Moretti, S.; Covino, S.; Cipriani, M.; D’Ellena, E.; Angeles, G.; Federici, E.; Savino, E.; et al. A comparative study of the antimicrobial and antioxidant activities of Inonotus hispidus fruit and their mycelia extracts. Int. J. Food Prop. 2019, 22, 768–783. [Google Scholar] [CrossRef]
  92. Novaković, A.; Karaman, M.A.; Milovanović, I.L.; Belović, M.; Rašeta, M.; Radusin, T.I.; Ilić, N.M. Edible mycorrhizal species Lactarius controversus Pers. 1800 as a source of antioxidant and cytotoxic agents. Hem. Ind. 2015, 70, 113–122. [Google Scholar] [CrossRef]
  93. Ozen, T.; Darcan, C.; Kaygusuz, Ö.; Turkekul, İ. The chemical content, antioxidant and antimicrobial assays of Lactarius controversus and Lactarius musteus: Two edible wild mushrooms from Giresun province of Turkey. Ann. Food Process. Preserv. 2016, 1, 1001. [Google Scholar]
  94. Dulay, R.M.R.; Cabrera, E.C.; Kalaw, S.P.; Reyes, R.G. Optimal conditions for basidiospore germination and morphogenesis of Philippine wild strain of Lentinus tigrinus (Bull.) Fr. Mycosphere 2012, 3, 926–933. [Google Scholar] [CrossRef]
  95. Dulay, R.M.; Arenas, M.C.; Kalaw, S.P.; Reyes, R.R.; Cabrera, E.C. Proximate Composition and functionality of the culinary-medicinal Tiger Sawgill mushroom, Lentinus tigrinus (higher basidiomycetes), from the Philippines. Int. J. Med. Mushrooms 2014, 16, 85–94. [Google Scholar] [CrossRef]
  96. Dulay, R.M.; Miranda, L.A.; Malasaga, J.S.; Kalaw, S.P.; Reyes, R.G.; Hou, C.T. Antioxidant and antibacterial activities of acetonitrile and hexane extracts of Lentinus tigrinus and Pleurotus djamour. Biocatal. Agricul. Biotech. 2017, 9, 141–144. [Google Scholar] [CrossRef]
  97. Sevindik, M. Investigation of antioxidant/oxidant status and antimicrobial activities of Lentinus tigrinus. Adv. Pharmacol. Pharm. 2018, 18, 1718025. [Google Scholar] [CrossRef] [PubMed]
  98. Mohammadnejad, S.; Pourianfar, H.R.; Drakhshan, A.; Jabaleh, I.; Rezayi, M. Potent antiproliferative and pro-apoptotic effects of a soluble protein fraction from culinary-medicinal mushroom Lentinus tigrinus on cancer cells. J. Food Meas. Charact. 2019, 13, 3015–3024. [Google Scholar] [CrossRef]
  99. Wang, S.; Bao, L.; Zhao, F.; Wang, Q.; Li, S.; Ren, J.; Li, L.; Wen, H.; Guo, L.; Liu, H. Isolation, identification, and bioactivity of monoterpenoids and sesquiterpenoids from the mycelia of edible mushroom Pleurotus cornucopiae. J. Agric. Food Chem. 2013, 61, 5122–5129. [Google Scholar] [CrossRef]
  100. Zhang, J.; Ma, Z.; Zheng, L.; Zhai, G.; Wang, L.; Jia, L.; Jia, L. Purification and antioxidant activities of intracellular zinc polysaccharides from Pleurotus cornucopiae SS-03. Carbohydr. Polym. 2014, 111, 947–954. [Google Scholar] [CrossRef] [PubMed]
  101. Tanaka, A.; Nishimura, M.; Sato, Y.; Sato, H.; Nishihira, J. Enhancement of the Th1-phenotype immune system by the intake of Oyster mushroom (Tamogitake) extract in a double-blind, placebocontrolled study. J. Tradit. Complement. Med. 2015, 6, 424–430. [Google Scholar] [CrossRef]
  102. Wu, X.; Huang, C.; Chen, Q.; Wang, H.; Zhang, J. A novel laccase with inhibitory activity towards HIV-I reverse transcriptase and antiproliferative effects on tumor cells from the fermentation broth of mushroom Pleurotus cornucopiae. Biomed. Chromatogr. 2013, 28, 548–553. [Google Scholar] [CrossRef] [PubMed]
  103. Jayakumar, T.; Thomas, P.A.; Sheu, J.R.; Geraldine, P. In vitro and in-vivo antioxidant effects of the oyster mushroom Pleurotus ostreatus. Food Res. Int. 2011, 44, 851–861. [Google Scholar] [CrossRef]
  104. Ianni, F.; Blasi, F.; Angelini, P.; Di Simone, S.C.; Angeles Flores, G.; Cossignani, L.; Venanzoni, R. Extraction optimization by experimental design of bioactives from Pleurotus ostreatus and evaluation of antioxidant and antimicrobial activities. Processes 2021, 9, 743. [Google Scholar] [CrossRef]
  105. Sahoo, S.; Gayakwad, T.; Shahi, S. Medicinal value of edible mushrooms: A review. Int. J. Health Sci. 2022, 6 (Suppl. S2), 8760–8767. [Google Scholar] [CrossRef]
  106. Cao, X.Y.; Liu, J.L.; Yang, W.; Hou, X.; Li, Q.J. Antitumor activity of polysaccharide extracted from Pleurotus ostreatus mycelia against gastric cancer in vitro and in vivo. Mol. Med. Rep. 2015, 12, 2383–2389. [Google Scholar] [CrossRef]
  107. El Domany, E.B.; Essam, T.M.; Ahmed, A.E.; Farghali, A.A. Biosynthesis physico-chemical optimization of gold nanoparticles as anti-cancer and synergic antimicrobial activity using Pleurotus ostreatus fungus. J. Appl. Pharm. Sci. 2018, 8, 119–128. [Google Scholar]
  108. Mkhize, S.S.; Cedric Simelane, M.B.; Mongalo, I.N.; Pooe, O.J. The effect of supplementing mushroom growing substrates on the bioactive compounds, antimicrobial activity, antioxidant activity of Pleurotus ostreatus. Biochem. Res. Int. 2022, 2022, 9436614. [Google Scholar] [CrossRef] [PubMed]
  109. Karim, R.; Rahman, F.; Rahman, R.; Tamannaa, Z.; Ghose, D.K.; Islam, N.; Hossain, T.; Islam, R.; Rahman, A. Hypoclycemic and antidyslipidemic potential of Pleurotus ostreatus in streptozotocin-induced diabetic rats. J. Adv. Biotechnol. Exp. Ther. 2020, 3, 49–55. [Google Scholar] [CrossRef]
  110. Agrawal, D.; Chourasia, A.; Ganeshpurkar, A.; Shrivastava, A.; Dubey, N. In vitro α-amylase and α-glucosidase inhibitory potential of Pleurotus ostreatus cv. Florida extract. Indian J. Biochem. Biophys. 2022, 59, 1016–1019. [Google Scholar]
  111. Razak, D.L.A.; Ghani, A.A.; Lazim, M.I.M.; Khulidin, K.A.; Shahidi, F.; Ismail, A. Schizophyllum commune (Fries) mushroom: A review on its nutritional components, antioxidative, and anti-inflammatory properties. Curr. Opin. Food Sci. 2024, 56, 101129. [Google Scholar] [CrossRef]
  112. Berikashvili, V.; Khardziani, T.; Kobakhidze, A.; Kulp, M.; Kuhtinskaja, M.; Lukk, T.; Gargano, M.L.; Venturella, G.; Kachlishvili, E.; Metreveli, E.; et al. Antifungal Activity of Medicinal Mushrooms and Optimization of Submerged Culture Conditions for Schizophyllum commune (Agaricomycetes). Int. J. Med. Mushrooms 2023, 25, 1–21. [Google Scholar] [CrossRef]
  113. Basso, V.; Schiavenin, C.; Mendoҫa, S.; de Siqueira, F.G.; Salvador, M.; Camassola, M. Chemical features and antioxidant profile by Schizophyllum commune produced on different agroindustrial wastes and byproducts of biodiesel production. Food Chem. 2020, 329, 127089. [Google Scholar] [CrossRef] [PubMed]
  114. Mišković, J.; Karaman, M.; Rašeta, M.; Krsmanović, N.; Berežni, S.; Jakovljević, D.; Piattoni, F.; Zambonelli, A.; Gargano, M.L.; Venturella, G. Comparison of two Schizophyllum commune strains in production of acetylcholinesterase inhibitors and antioxidants from submerged cultivation. J. Fungi 2021, 7, 115. [Google Scholar] [CrossRef] [PubMed]
  115. Onsrisawat, P.; Rodthong, S.; Yahuafai, J.; Urairong, R. Hepatoprotective and antioxidant properties of Schizophyllum commune fruiting body. J. Curr. Sci. Tech. 2022, 12, 615–628. [Google Scholar]
  116. Al-Azad, S.; Ping, V.C.A. Antioxidant properties and antimicrobial activity in the extracts of two edible mushroom, Pleurotus sajor caju and Schizophyllum commune. Adv. Biosci. Biotechnol. 2022, 13, 352–361. [Google Scholar] [CrossRef]
  117. Daengrot, C.; Rukachaisirikul, V.; Tadpetch, K.; Phongpaichit, S.; Bowornwiriyapan, K.; Sakayaroj, J.; Shen, X. Penicillanthone and penicillidic acids A–C from the soil-derived fungus Penicillium aculeatum PSU-RSPG105†. RSC Adv. 2016, 6, 39700. [Google Scholar] [CrossRef]
  118. Krishnamurthy, S.; Murthy, K.N.; Thirumale, S. Characterization of ankaflavin from Penicillium aculeatum and its cytotoxic properties. Nat. Prod. Res. 2018, 34, 1630–1635. [Google Scholar] [CrossRef]
  119. Hawas, U.W.; Abou El-Kassem, L.T.; Ahmed, E.F.; Alghamdi, R.A. Bioactive sulfonyl metabolites from the Red Sea endophytic fungus Penicillium aculeatum. Nat. Prod. Res. 2021, 36, 2713–2721. [Google Scholar] [CrossRef]
  120. Martin, J.F. Insight into the genome of diverse Penicillium chrysogenum strains: Specific genes, cluster duplications and DNA fragment translocations. Int. J. Mol. Sci. 2020, 21, 3936. [Google Scholar] [CrossRef]
  121. Holzknecht, J.; Kühbacher, A.; Papp, C.; Farkas, A.; Marcos, J.F.; Manzanares, P.; Tóth, G.K.; Galgóczy, L.; Marx, F. The Penicillium chrysogenum Q176 antimicrobial protein PAFC effectively inhibits the growth of the opportunistic human pathogen Candida albicans. J. Fungi 2020, 6, 141. [Google Scholar] [CrossRef]
  122. Orfali, R.; Perveen, S.; AlAjmi, M.F.; Ghaffar, S.; Rehman, M.T.; Alanzi, A.R.; Gamea, S.B.; Essa Khwayri, M. Antimicrobial activity of dihydroisocoumarin isolated from wadi lajab sediment-derived fungus Penicillium chrysogenum: In vitro and in silico study. Molecules 2022, 27, 3630. [Google Scholar] [CrossRef] [PubMed]
  123. Niu, S.; Xia, M.; Chen, M.; Liu, X.; Li, Z.; Xie, Y.; Shao, Z.; Zhang, G. Cytotoxic polyketides isolated from the deep-sea-derived fungus Penicillium chrysogenum MCCC 3A00292. Mar. Drugs 2019, 17, 686. [Google Scholar] [CrossRef] [PubMed]
  124. El-Sayed, A.; Enan, G.; Al-Mohammadi, A.; Moustafa, H.A.; El-Gazzar, N. Detection, purification and elucidation of chemical structure and antiproliferative activity of taxol produced by Penicillium chrysogenum. Molecules 2020, 25, 4822. [Google Scholar] [CrossRef] [PubMed]
  125. Chen, J.; Huo, L.N.; Gao, Y.; Zhang, Y.L.; Chen, Y. Two new N-acetyl-D-glucosamine derivatives from the medical algae derived endophytic fungus Penicillium chrysogenum. Nat. Prod. Res. 2022, 36, 3988–3991. [Google Scholar] [CrossRef]
  126. Al-Saleem, M.S.; Hassan, W.H.; El Sayed, Z.I.; Abdel-Aal, M.M.; AbdelMageed, W.M.; Abdelsalam, E.; Abdelaziz, S. Metabolic profiling and in vitro assessment of the biological activities of the ethyl acetate extract of Penicillium chrysogenum “endozoic of Cliona sp. Marine sponge” from the Red Sea (Egypt). Mar. Drugs 2022, 20, 326. [Google Scholar] [CrossRef]
  127. Avila, C.F.; Moreira, G.M.; Nicolli, C.P.; Gomes, L.B.; Abreu, L.M.; Pfenning, L.H.; Haidukowski, M.; Moretti, A.; Logrieco, A.; Del Ponte, E.M. Fusarium incarnatum-equiseti species complex associated with Brazilian rice: Phylogeny, morphology and toxigenic potential. Int. J. Food Microbiol. 2019, 306, 108267. [Google Scholar] [CrossRef] [PubMed]
  128. Das, M.; Prakash, H.S.; Nalini, M.S. Antioxidative and antibacterial potentials of fungal endophytes from Justicia wynaadensis heyne: An ethnomedicinal rain forest species of western ghats. Asian J. Pharm. Clin. Res. 2017, 10, 203–209. [Google Scholar] [CrossRef]
  129. Chua, R.W.; Song, K.P.; Ting, A.S.Y. Characterization and identification of antimicrobial compounds from endophytic Fusarium incarnatum isolated from Cymbidiumorchids. Int. Microbiol. 2024, 27, 977–992. [Google Scholar] [CrossRef] [PubMed]
Figure 1. (a) Freshwater vegetation linked with the observed fungal taxa; (b) ecological category of freshwater macro- and microfungi.
Figure 1. (a) Freshwater vegetation linked with the observed fungal taxa; (b) ecological category of freshwater macro- and microfungi.
Jof 11 00054 g001
Figure 2. Percentages of freshwater fungi with mentioned medicinal properties.
Figure 2. Percentages of freshwater fungi with mentioned medicinal properties.
Jof 11 00054 g002
Table 1. Riparian habitats, ecological role, and medicinal properties of freshwater macromycetes observed in previous study by Mirabile et al., 2023 [9].
Table 1. Riparian habitats, ecological role, and medicinal properties of freshwater macromycetes observed in previous study by Mirabile et al., 2023 [9].
TaxaRiparian HabitatEcological CategoriesMedicinal PropertiesReferences
Amanita vaginata (Bull.) Lam.Mixed forest of Alnus cordata (Loisel.) Duby, Carpinus betulus L., Fraxinus ornus L.EctomycorrhizalAntioxidant activity; ferrous ion chelating ability; antimicrobial activity; esterolytic activity[11,12,13]
Armillaria mellea (Vahl) P. Kumm.Stumps of Populus alba L., Salix alba L., Tamarix africana Poir., Alnus cordataNecrotroph parasiteImmune regulation; tumor inhibition;
antioxidant activity; anti-aging effects; hypoglycemic effect; antimicrobial activity; anti-inflammatory effect; antidiabetic potential; liver protection; reducing DNA damage; anti-Alzheimer activity
[14,15,16,17,18,19,20,21,22,23]
Armillaria tabescens (Scop.) Emel.Stumps of Populus alba, Salix albaNecrotroph parasiteAntioxidant activity; metal chelating activity[24,25,26]
Astraeus hygrometricus (Pers.) Morgan Mixed forest of Tamarix africana, Salix alba,
Populus alba
Terricolous saprotrophAntioxidant, antimicrobial, antiparasitic, anti-diabetic, immunomodulatory, hepatoprotective, anti-inflammatory, cardioprotective, anticancer, chemopreventive activities[27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46]
Auricularia auricula-judae
(Bull.) Quél.
Stumps and trunks of Populus alba, Salix albaSaprotroph on woodSkin wound-healing potential; antimicrobial, antioxidant, antidiabetic, anti-inflammatory, anti-obesity, anticancer, anti-radiation, immunomodulatory, hypolipidemic, anticoagulant activities; [47,48,49,50,51,52,53,54]
Bjerkandera adusta
(Willd.) P. Karst.
Stumps and trunks of Populus alba, Salix albaNecrotroph parasitesAntimicrobial and antioxidant activities[55,56,57,58,59]
Bovista nigrescens Pers.Mixed forest of Salix alba, Populus alba, Eucalyptus camaldulensis Dehnh.Saprotroph on litterAntimicrobial and antioxidant activities[60,61]
Calocybe gambosa (Fr.) DonkMixed forest of Salix alba, Populus albaTerricolous saprotrophAntioxidant activity[62,63,64]
Candolleomyces candolleanus
(Fr.) D. Wächt. & A. Melzer
Stumps of Populus alba, Salix alba,
Tamarix africana, Alnus cordata
Saprotroph on woodAntioxidant, antimicrobial, antiproliferative activities[65,66,67,68]
Collybia dryophila
(Bull.) P. Kumm.
Gymnopus dryophylus (Bull.) Murr
Mixed forest of Alnus cordata, Pinus nigra J. F. Arnold,
Castanea sativa Mill., Salix alba, Populus alba
Saprotroph on litterAnti-inflammatory activity[69]
Coprinus comatus
(O.F. Müll.) Pers.
Mixed forest of Salix alba, Populus alba,
Alnus cordata, Fraxinus ornus, Castanea sativa
Saprotroph on litterAntioxidant, anticancer, antiandrogenic, hepatoprotective,
acetylcholinesterase inhibitory, antiinflammatory, antidiabetic, antiobesity, antibacterial,
antifungal, antinematode, anticancer, and antiviral activities
[70,71,72,73,74,75,76]
Cyclocybe cylindracea
(DC.) Vizzini & Angelini
Stumps of Populus alba, Salix albaSaprotroph on woodAntioxidant activities[77,78,79]
Hypsizygus ulmarius
(Bull.) Redhead
Stumps of Populus alba, Salix albaSaprotroph on woodAntioxidant, anti-inflammatory, antibacterial, antitumor activities[80,81,82,83,84,85,86,87]
Inonotus hispidus
(Bull.) P. Karst.
Trunks of Populus alba, Salix albaSaprotroph on woodAntioxidant, anticancer, immunomodulatory, antimicrobial activities[87,88,89,90,91]
Lactarius controversus Pers.Mixed forest of Salix alba, Populus alba, Alnus cordata, Fraxinus ornus, Castanea sativaEctomycorrhizalAntioxidant and antimicrobial activities[92,93]
Lentinus tigrinus
(Bull.) Fr.
Mixed forest of Salix alba, Populus alba, Alnus cordata, Fraxinus ornus,
Castanea sativa
Saprotroph on woodAntioxidant, antibacterial, hypoglycaemic activities; Anticancer potential; [94,95,96,97,98]
Pleurotus cornucopiae (Paulet) Quél.Stumps of Populus albaSaprotroph on woodAntioxidant, anticancer, immunomodulatory activities[3,5,99,100,101,102]
P. ostreatus
(Jacq.) P. Kumm.
Stumps of Populus albaSaprotroph on woodAntioxidant, antimicrobial, antidiabetic, anticancer, anti-infiammatory, immunomodulatory, antihypercholesterolemic, antihypertensive, hepatoprotective, antiaging activities[3,103,104,105,106,107,108,109,110]
Schizophyllum commune
(Fr.)
Stumps and trunks of Salix alba, Populus albaSaprotroph on woodAntioxidant, anti-inflammatory, hepatoprotective, antimicrobial activities[111,112,113,114,115,116]
Table 2. Medicinal properties and substrate of isolation of freshwater micromycetes.
Table 2. Medicinal properties and substrate of isolation of freshwater micromycetes.
TaxaSubstrate of IsolationMedicinal PropertiesReferences
Penicillium aculeatumLeaves of Phragmites australisAntimicrobial activity[117,118,119]
P. chrysogenumRoots of P. australisAntifungal, anticancer, antimicrobial, antioxidant activities [120,121,122,123,124,125,126]
Fusarium incarnatumLeaves and roots of P. australisAntimicrobial and antioxidant activity[127,128,129]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cicero, I.; Mirabile, G.; Venturella, G. Potential Medicinal Fungi from Freshwater Environments as Resources of Bioactive Compounds. J. Fungi 2025, 11, 54. https://doi.org/10.3390/jof11010054

AMA Style

Cicero I, Mirabile G, Venturella G. Potential Medicinal Fungi from Freshwater Environments as Resources of Bioactive Compounds. Journal of Fungi. 2025; 11(1):54. https://doi.org/10.3390/jof11010054

Chicago/Turabian Style

Cicero, Ilenia, Giulia Mirabile, and Giuseppe Venturella. 2025. "Potential Medicinal Fungi from Freshwater Environments as Resources of Bioactive Compounds" Journal of Fungi 11, no. 1: 54. https://doi.org/10.3390/jof11010054

APA Style

Cicero, I., Mirabile, G., & Venturella, G. (2025). Potential Medicinal Fungi from Freshwater Environments as Resources of Bioactive Compounds. Journal of Fungi, 11(1), 54. https://doi.org/10.3390/jof11010054

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop